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ABSTRACT 
Studies of protein conformational dynamics can lead to a deeper understanding of 
biological functions of proteins, protein/protein interactions, catalysis and allostery. Most of the 
conformers involved in biological pathways are short-lived. These conformers represent 
challenging analytical targets since they are weakly populated at equilibrium and demand ultra-
rapid online analytical techniques. To address this demand, the development of new tools that 
will offer enhanced time and spatial resolution in measurements is essential. Towards that end, 
we took advantage of microfluidics to fabricate custom polymeric devices that would allow 
direct mass spectrometric measurements of protein dynamics. This dissertation presents 
successful development of new tools and demonstrates their practical applications in studying 
dynamics of weakly structured regions of proteins on the millisecond time scale, which is 
unattainable by conventional biophysical techniques. 
This thesis introduces a simple, rapid, inexpensive and easily modifiable fabrication 
protocol which enables the integration of multiple functionalities on a single platform that 
accommodates complete ‘bottom up’ continuous/pulse labelling Hydrogen-deuterium exchange 
(HDX) work flow. These integrated devices can be directly interfaced with mass spectrometry as 
custom electrospray ionization (ESI) sources to conduct site specific mass spectrometric protein 
conformational analysis.  The continuous HDX labelling device enables structural analysis of 
ubiquitin and distinguishes loop dynamics in cytochrome c. The effect of ligand binding in 
conformational dynamics in a molten globule protein DAHP synthase was also monitored via 
continuous HDX labelling. Another analogous device, capable of performing millisecond HDX 
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pulse labelling, reveals allosteric hot spots in TEM-1 which is an antibiotic resistant β-lactamase. 
Complementary experiments with multiple antibiotics compare the allosteric responses of TEM-
1 upon inhibitor or substrate binding. The results exhibit an exciting correlation between 
allosteric dynamic responses and functionally relevant mutations at the periphery of the protein. 
This strong correlation demonstrates that this device can be applied in predicting sites of 
probable mutations. This dissertation successfully introduces integrated microfluidic devices that 
represent a promising tool for studying dynamics of weakly structured proteins, intrinsically 
disordered proteins and allostery.  
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CHAPTER 1 
INTRODUCTION 
1.1 Conformational Dynamics 
Understanding the structure and dynamics of proteins at molecular level with high 
resolution is one of the most compelling challenges in bioanalytical chemistry. Proteins are the 
most important functional biomolecules in biological system. Virtually they participate in almost 
every process within living organisms- catalyzing metabolic reactions, replicating DNA, 
responding to stimuli through post translational modification, and transporting molecules from 
one location to another and many more [1]. Protein molecules are highly dynamic rather than 
static; they function by changing their conformation ensembles [2, 3]. It is now widely 
recognized that knowledge about static structure alone is not often sufficient to understand real-
time protein functions. The details of how proteins do what they do – remains one of the 
challenging questions in biochemistry [4, 5]. This challenge inspired us to improve currently 
available analytical techniques to investigate protein fluctuations on the millisecond time scale. 
Using our novel technique, we were able to distinguish dynamic properties of different regions 
of proteins which are inaccessible via current approaches.  
Proteins are large biopolymers made of twenty basic amino acids which can be 
assembled in a very specific permutations and combinations to craft complex proteins. Amino 
acids are attached together by strong covalent polypeptide bonds forming the backbone of a long 
chain protein. Nascent proteins are linear polymers that must fold into precise three-dimensional 
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conformations commonly termed as their ‘native’ form which are usually ordered arrangements 
and low energy conformational ensembles.  Rather than undergoing randomized conformational 
search, initially random coils of protein follow specific folding pathways to achieve highly 
specific three-dimensional arrangements that are thermodynamically stable under physiological 
conditions. Folding mechanisms are dictated ultimately by the primary amino acid sequence of 
protein. Each amino acid has its own unique Chemistries as each of them has a unique functional 
group in its side chain. Relatively weak noncovalent interactions between side chains and the 
functional groups of the polypeptide backbone play crucial role in folding process. In order to 
function, native protein needs to access higher energy conformational ensembles which are 
relatively less ordered. During folding/unfolding, the protein rearranges itself via many 
‘transient’ conformations which are structurally and energetically similar to each other but 
usually indistinguishable by contemporary optical methods.  
While rearranging conformations via (un)folding mechanisms, proteins may undergo 
‘misfolding’ to attain thermodynamically more favourable highly ordered states compared to 
their native states. These transient conformations and misfolded proteins often cause many 
modified or toxic functionalities resulting in pathological states [6-8]. For example Alzheimer’s, 
a neurodegenerative disease, is believed to result from the accumulation of amyloid fibrils 
composed of misfolded proteins. Several other human disease including diabetes, Parkinson’s, 
Creutzfeldt-Jacob disease and Huntington's disease have also been associated with 
misfolded proteins [9-12]. Therefore, understanding a protein’s folding mechanism and/or its 
dynamics can provide insights to combat these critical concerns. Fortunately, experimental and 
theoretical/computational investigations have resulted in substantial progress in this direction 
over the past few years.  
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Scientists have utilized an ‘energy landscape’ of proteins (Figure 1.1) to describe 
protein’s potential surface. As evident from Figure 1.1, many of the transient states are gateways 
to the folding and aggregation regions of the protein’s conformational energy landscape [13-15]. 
Therefore, knowledge of conformational fluctuations may represent a promising therapeutic 
strategy in designing drug molecules to prevent protein misfolding and/or aggregation [16, 17]. 
 
 
 
 
 
 
 
 
 
Figure 1.1. The ‘energy landscape’ of proteins. The purple surface shows the multitude of 
conformations 'funneling' to the native state via intramolecular contacts and the pink area shows 
the conformations moving toward amorphous aggregates or amyloid fibrils via intermolecular 
contacts. Both parts of the energy surface overlap. Aggregate formation can occur from 
intermediates populated during de novo folding or by destabilization of the native state into 
partially folded states and is normally prevented by molecular chaperones. Cell-toxic oligomers 
may occur as off-pathway intermediates of amyloid fibril formation. This figure is adapted from 
reference [18]. 
4 
 
1.2 Allostery in Proteins 
Allostery is a biological phenomenon of fundamental importance to many biological 
processes, including but not limited to cell signaling and the regulation of metabolism [19]. 
Allostery is the process where very subtle changes in structure at one location of a protein can be 
transferred to one or more distinctly distant sites, causing a change in biological reactivity. 
Allosteric interactions are often triggered by small changes at or around the active site of a 
protein via disruption of ionic linkages at specific contact points. One of the most famous 
example of allostery is oxygen binding in hemoglobin [1]. When the first oxygen molecule binds 
to one of the subunits of haemoglobin, a message is communicated to the other subunit via subtle 
conformational (structural) changes. This concept extends the possibility of using small molecule 
ligands, often known as ‘effectors’, to a protein at one site to induce conformational changes that 
will affect the subsequent binding of a second ligand at another site. Allosteric changes in 
conformation induced by ligand binding can also give rise to either reduction (allosteric 
inhibition) or enhancement (allosteric activation) of activity, depending on the particular system. 
Each enzyme molecule has only a limited number of active sites, usually no more than one per 
subunit which accounts for substrate saturation effect in enzyme kinetics. In addition to the 
active sites, allosteric enzymes have effector specific binding sites known as regulatory sites 
which are physically distinct from its active site. Effector molecules act by reversible, 
noncovalent binding to regulatory sites while allosteric ligand binding can be either reversible or 
irreversible.  
Allosteric enzymes are substantially larger than non-regulatory enzymes which behave 
differently upon binding to any specific effector.  Allosteric regulation can be ‘homotropic’ 
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where the allosteric modulator is a substrate for its target enzyme, as well as a regulatory 
molecule of the enzyme's activity. Most often, a homotropic modulator is an activator of the 
enzyme. When the substrate and the effector are different species, the observed allosteric 
regulation is heterotropic. A heterotropic allosteric modulator may be either an activator or an 
inhibitor of the enzyme. For example, O2 is a homotropic allosteric modulator of heamoglobin as 
binding of one O2 enhances the probability of second O2 binding while H
+
, CO2, and 2,3-
bisphosphoglycerate are heterotropic allosteric modulators of heamoglobin. Furthermore, some 
allosteric proteins are capable of demonstrating both homotropic and heterotropic interactions as 
they can be regulated by both their substrates and other molecules. 
Since allosteric regulation is highly selective, allosteric sites may represent a potential 
target for novel drug development.  Allostery is an inherently dynamic phenomenon, since 
information must be transmitted from the allosteric site to the active site by subtle structural 
changes. In spite of individual successes in understanding the structural elements of allostery in 
well-investigated systems, much less success has been achieved in identifying a set of 
quantitative and transferable ground rules that provide an understanding of how allostery works 
in general. Towards this challenge, we have applied our novel device to study allosteric systems 
in TEM-1 beta lactamase which revealed some unprecedented correlation between allostery and 
functionally relevant natural mutations in TEM-1.  
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1.3 Mass Spectrometry 
Mass spectrometry has become an indispensable analytical technique because of its 
supreme sensitivity, speed and diversity of application [20]. Over last two decades, continuous 
instrumental improvements have raised it to be the most widely used techniques in bio-analytical 
chemistry, including proteomics, metabolomics, high throughput drug discovery and 
metabolism, protein structure and dynamics etc.  It is routinely applied as the main analytical 
tool in forensic science, environmental science, food control, natural products or process 
monitoring, trace elemental analysis, health and beauty product development, and in many other 
industries [21] .Furthermore, its unprecedented capability to yield analytical information makes 
it also suitable for studying fundamental processes such as ion-molecule reactions, reaction 
kinetics, inorganic chemical reaction and mechanisms, atomic physics, geochronology and 
determination of thermodynamic parameters ( ΔGºf, Ka, etc.), and many others [21-23]. 
 
1.3.1 Principles.  The basic principle of mass spectrometry (MS) is to generate charged ions 
from desired analyte by a variety of techniques, separate theses ions according to their mass-to-
charge ratio (m/z) and then detect them qualitatively and/or quantitatively. Moreover, there are 
some instruments that are capable of separating ions based on the size and shape in addition to 
their m/z. A mass spectrometer consists of three major components: the ion source, the mass 
analyzer and the detector which operates under high vacuum conditions. All modern MS 
instruments are completely computer controlled including data acquisition and data processing 
and even instrument calibration. A mass spectrum is the two dimensional representation of signal 
intensity or ion counts versus m/z where peak intensity directly reflects the abundance of the ions 
registered in the detector.  Figure 1.2 shows a general scheme of a mass spectrometer.  
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Figure 1.2. A general scheme of a typical mass spectrometer. Several types of sample inlets can 
be interfaced to ion source which can be either commercially available source or custom made. 
Highly efficient turbo pumps enable the transfer of charged ions into the mass analyzer to 
separate them. A ‘back end’ detector senses these ions and signals are processed by computer 
controlled data system. 
 
1.3.2 Ionization Techniques. The choice of ion generation is dependent on the nature of analyte 
and most crucial for the desired application. The number of currently available ionization 
techniques is quite large and new ion generation methods are continuously being developed. The 
classical procedure of gas phase ionization such as electron ionization (EI), chemical ionization 
(CI), field ionization (FI) etc. are very energetic and cause extensive fragmentation, thus their 
use is limited to volatile or thermally stable compounds. Some ion sources like inductive coupled 
plasma or glow discharge are suitable for isotopic ratio measurements as they provide extremely 
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accurate quantitative data. However, large fragile analytes like proteins or noncovalently bound 
complexes are only amenable to soft ionization techniques like electrospray ionization (ESI), 
desorption electrospray ionization (DESI) and matrix-assisted laser desorption ionization 
(MALDI).  All of these ionization approaches can be implemented under atmospheric pressure 
while maintaining the structural integrity of the analyte. Additionally, singly or multiply charged 
ions are produced from analytes depending on the condition and ionization technique used.  
Since ESI is considered one of the most compatible techniques for studying intact proteins, it 
was selected for current studies to transfer proteins and other analytes into the gas phase.  
 
1.3.2.1 Electrospray Ionization.  Electrospray ionization (ESI) is a gentle ionization technique 
that was first introduced by Dole and coworkers in 1968 [24]. In 1984, Yamashita and Fenn 
successfully coupled ESI to MS to ionize intact proteins directly from solution to the gas phase 
environment of mass spectrometers [25, 26]. Soon after, ESI was adopted as the preferred 
ionization technique for large, non-volatile biomolecules, starting a new era of MS-enabled 
chemical and biological studies. Fenn and Tanaka (who developed MALDI) were awarded 
Nobel Prize in 2002 for their transformational contribution to MS-based science. In ESI, sample 
is dissolved in an appropriate volatile solvent and transported through a capillary placed at high 
positive or negative potential. The ions are generated by applying a potential difference of 2-6 
kV between this needle and a counter-electrode that are separated by 0.3 – 2 cm [21].  The 
electric field causes charge accumulation on the surface of solvent at the tip of the capillary 
which then form a cone shaped liquid jet, known as Taylor cone. Eventually the charge repulsion 
breaks the Taylor cone into a highly charged spray of droplets (Figure 1.3).   
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Figure 1.3. Schematic depiction of an ESI source operated at positive ion mode, adapted from 
reference [27].  Shown to the left is a thin metal capillary containing analyte solution where high 
electric field potential cause the formation of a Taylor cone. In a positive ion mode, positively 
charged particles congregate at the tip of the Taylor cone, resulting in the ejection of positively 
charged parent droplets at the liquid-air interface, while negatively charged particles align to the 
outer walls of the capillary (the opposite occurs for negative ion mode). 
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These droplets are then ejected from the Taylor cone and shrink through evaporation, most often 
assisted by a coaxial flow of inert nitrogen known as the nebulizer gas.  During this evaporation 
process, all the charges begin to concentrate on the droplet surface. Eventually Coulombic 
repulsion overcomes the surface tension resulting in the release of numerous solvent-stripped 
charged ions at atmospheric pressure. These ions are then attracted by the oppositely charged 
curtain plate and pass through a small aperture into an intermediate vacuum region. An electric 
field focuses these ions to travel through a small orifice transferring them into the high vacuum 
zone of mass analyzer.  
Though ESI is a widely used ionization technique, its exact mechanism of ion formation 
is still not well understood and there are many theories proposed to explain the mechanisms of 
multiple charged ion formation. A classical model of ESI, the Charged Residue model (CRM), 
was introduced by Dole in 1968. It assumes complete desolvation process is achieved via 
successive loss of all solvent molecules and leaving a ‘charge  residue’ on the molecules [24]. A 
later theory, the Ion Evaporation model (IEM) proposed by Iribarne and Thompson, describes 
the formation of desolvated ions through direct field assisted evaporation from the surface of 
highly charged microdroplets [28, 29]. Recently Konermann proposed another model known as 
Chain Ejection model (CEM) that describes the production of a multiply charged stretched out 
ion by long chain polymers or biomolecules like protein, more particularly for unfolded protein 
[30]. In summary, IEM describes generation of smaller ion while CRM and CEM holds valid for 
large molecule release mechanism. These three ion release mechanisms are compared on Figure 
1.4. 
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Figure 1.4. Summary of different ESI mechanisms. (a) IEM: Small ion ejection from a charged 
nano droplet.  (B) CRM: Release of a globular protein into the gas phase. (C) CEM: Ejection of 
an unfolded protein. This figure is adapted from reference [30]. 
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1.3.3 Mass Analyzers. A mass analyzer is the component of the MS that separates charged 
species according to their mass-to-charge ratio (m/z) and outputs them to the detector where they 
are detected as digital signals.  Currently there are several types of mass analyzers available 
commercially such as quadrupole mass filter (Q), time-of-flight (TOF), magnetic sector (B), 
quadrupole ion trap (QIT ), Linear quadrupole ion trap (LTQ), Fourier transform orbitrap (FT-
OT), Fourier transform ion cyclotron resonance (FTICR), accelerator mass spectrometry (AMS) 
[31]. All of these instruments use static or dynamic electric and magnetic fields, sometimes alone 
or in combination.  However, the basic differences between different types of analyzer are in the 
manner in which they utilize electric or magnetic fields to achieve separation. Each mass 
analyzer has its advantages and limitations that should be considered before selecting it for a 
particular application. The performance of a mass analyzer is typically considered in terms of 
certain features: resolution and mass accuracy, mass range, possibility of tandem measurement, 
precision of isotopic pattern, analysis speed etc. This dissertation work was carried out on a 
hybrid instrument Qq-TOF (QStar Elite) form AB SCIEX, Concord, ON. 
 
1.3.3.1 Quadrupole time-of-flight (Qq-TOF). The quadrupole time-of-flight (Qq-TOF) is a 
high performance hybrid mass spectrometer specially designed for protein identification and 
characterization using two quadrupoles (Q1 and Q2) to select and/or transmit ions to the TOF 
region for detection (Figure 1.5 a).  Additionally it has another quadrupole (Q0) before the 
functional analyzer (Q1) for ion focusing and collisional cooling that ensures maximum ion 
transmission. The quadrupole analyzers use the trajectories in oscillating electric fields to 
separate ions according to their m/z ratio. The first mass analyzer is a linear quadrupole (Q) that 
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employs a combination of direct current (DC) and radio frequency (RF) potential whereas the 
second one is a RF –only quadrupole (q). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. a) Ion path chamber detail in the QStar Elite system. b) Arrangement of four parallel 
cylindrically shaped rods of Quadrupole analyzer. The figures are adapted from user manual of 
Qstar Elite. 
a) 
b) 
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Quadrupole analyzers are made up of four parallel cylindrically shaped rod electrodes 
[32, 33]. These rods are arranged symmetrically in space extending in the z-direction and 
mounted in a square configuration (Figure 1.5 b).  Opposite rods are connected in pairs where 
electrical potential is applied that comprise both DC and RF component.  At any given time, 
potential experienced by both pairs of rods have same magnitude but opposite sign.  A positive 
ion entering the quadrupole assembly in the z-direction will be drawn towards a negative rod. 
The magnitude and signs of potential applied on the rods are periodic ensuing an alternating 
attraction and repulsion in x- and y- direction in time. Ions of a specific mass have certain 
oscillation amplitude. Therefore, for any given values of DC and RF potentials, only a certain 
m/z range ions experience proper potential to have a stable trajectory. These ions travel in z-
direction and finally reach the detector while ions that do not have the right m/z potential range 
will collide with the rods and discharge. Therefore, m/z range scanning is dependent on the ratio 
of DC and RF voltages. A mass spectrum is acquired by utilizing the first Q for mass scanning. 
The second quadrupole (q) of Qq-TOF is operated in the RF- only mode where a wide m/z range 
is allowed to pass through the system. Additionally, it can perform as a collision cell: neutral gas 
can be introduced to this region allowing fragmentation of desired ions that can be separated by 
the TOF analyzer on downstream.  
 A time-of-flight (TOF) analyzer separates ions by time where separation is based on the 
kinetic energy and velocity of the ions [34]. Ions of different m/z are allowed to drift through a 
field free region under very high vacuum. All the ions entering the accelerating region of TOF at 
any given time ideally have same kinetic energy but different velocity depending on their mass. 
During their flight along a known path, the lighter ions will go reach the detector faster than the 
heavier ones, thus arrival times can be converted into a mass spectrum. The TOF of the Q-star 
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Elite compensates any kinetic energy distribution by an electrostatic mirror that lies at a higher 
potential than the acceleration potential. This reflector allows the faster ions to penetrate deeper 
into the electric field than the slower ones which increases the flight path of the ions with 
slightly faster initial velocity. The micro channel plate (MCP) detector outputs the signal via 
time-to-digital converters (TDC) which is then processed by computer. 
 
1.4 Mass Spectrometry Based Techniques for Studying Protein 
Conformations and Dynamics. 
 
Understanding protein structures and their dynamics at high resolution is of great interest 
to resolve many biological mysteries. Nuclear magnetic resonance (NMR) and X-ray 
crystallography are two main tools of structural biology that enable complete 3D protein 
structural analysis. However, proteins are inherently dynamic and their dynamics is often related 
to their biological functions: protein-protein interactions, ligand binding, complex formation or 
structural effects of post translational modifications are strongly modulated by conformational 
perturbations. Unfortunately, experimental probing of many of these conformation changes is 
beyond the range of classical structural biology approaches using NMR and X-ray. X-ray is 
unable to provide dynamic views of low energy state conformations in real time scale and the 
data acquisition time in NMR is longer than the time scale at which the structural changes occur 
in biological processes. Additionally, both of these techniques have some significant limitations 
to determine the structures and dynamics of proteins or/and their complexes including size (upto 
50 kDa), crystallizability, diffraction quality of crystals, solubility and amounts of sample 
required. On the other hand, in recent years other techniques like electron microscopy (EM) or 
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tomography techniques have substantially improved to perform at low temperature making them 
more appropriate for monitoring whole cells or extremely large complexes. This leaves a ‘size 
gap’ in the range of proteins or protein complexes 50-200 kDa [35]. Structural mass 
spectrometry (MS) has been emerged as a tool that can fill this technological gap.  
The usage of MS in structural studies has dramatically increased with the technological 
advances in terms of its ability to provide highly resolved structural information. The three main 
techniques of structural MS include Hydrogen-deuterium exchange (HDX), covalent labeling 
strategies (mainly hydroxyl radical) and chemical cross linking [22]. In the present work, ESI-
MS HDX approach was used on a microfluidic platform, facilitating site specific conformational 
studies on several proteins and their complexes.   
 
1.4.1 Hydrogen-Deuterium Exchange (HDX) Mass Spectrometry. Hydrogen-deuterium 
exchange (HDX) is a powerful and commonly-used technique in both NMR and MS based 
protein structure and dynamics studies. In the early 1990s, HDX was combined with MS, 
inspired by related NMR methods. Combining the information from classical approaches with 
HDX data, a thorough understanding of protein functions can be achieved [36-38]. HDX is a 
sensitive probe for solvent accessibility and detecting the presence or absence of hydrogen 
bonding or other sequestration of labile hydrogen atoms from solvent within the protein in 
solution [39, 40].  However, HDX is mostly dependent on the H- bonding present in any protein. 
The amide protons of protein backbone are exchangeable with the deuterium atoms from 
the solvent surrounding the protein at different measurable exchange rates. The amide protons 
that are more solvent accessible or lack strong hydrogen bonding will undergo exchange faster 
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than that are buried participating in hydrogen bonds [38, 41]. The mass increase due to more 
deuterium incorporation instead of hydrogen is monitored via mass spectrometry. The rate at 
which deuterium is taken up reflects protein’s structural stability and solvent accessibility.  
 
1.4.1.1 Hydrogen-Deuterium Exchange (HDX) Mechanism.  Hydrogen-deuterium exchange 
(HDX) reactions can progress via three different mechanisms: base-catalyzed exchanged and 
two different acid-catalyzed exchanges [42]. However, the based-catalyzed mechanism (Figure 
1.6) is more relevant to biological process and used for current dissertation work.  
 
 Figure 1.6. Based-catalyzed hydrogen-deuterium exchange (HDX) mechanisms of amide 
protons in peptides or proteins. 
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The rate of backbone amide hydrogen the exchange is a function of pH which usually 
plays a vital role in controlling reaction time in HDX-MS based techniques. Figure 1.7 shows the 
pH dependence of several types of labile hydrogens that are common in protein or peptide. Most 
of the backbone amides have a lower pHmin values compared to the side chain protons [43].   
 
 
Figure 1.7. Hydrogen-deuterium exchange (HDX) mechanism is a function of pH of amide 
protons in peptides or proteins. This figure is adapted from a book [22]. 
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In HDX experiments, the pH is often adjusted to 2.5 after labeling to quench the 
backbone amide exchange while most of the side chains continue exchanging resulting in a loss 
of label.  Therefore, the observed HDX profile is essentially a contribution of only the backbone 
amides on an entire peptide or protein except proline (which has no backbone amide) and the 
first reside on a peptide (corresponding to the free N-terminus). Additionally, HDX is also 
influenced by certain other factors such as, temperature, solvent, pressure, adjacent side chains 
and ionic strength. 
The hydrogen/deuterium exchange rate of an unstructured protein is called the ‘intrinsic’ 
rate (kint) which is expressed as the sum of acid, base and water mediated catalyzed contributions 
at a certain pH (Equation 1.1) [43, 44]. 
kint = kacid [H3O
+
] + kbase [OH
-
] + kwater      (1.1) 
 
Based on a simple two state kinetic model, Englander et.al related observed HDX kinetics of 
backbone amide to thermodynamics by the following formulas. 
      
                  (1.2) 
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Where kop and kcl are the rates at which the amide hydrogen converts from closed state to 
open state and vice versa [45].  When HDX is faster than the rate of closing (kint>> kcl)  it follows 
a EX1 mechanism. On the other hand, for most proteins at or under neutral pH, kcl>> kint  and 
HDX is mediated via EX2 mechanism and equation 1.2 is simplified as below [46]. A detail of 
this equation is also discussed in Data Analysis Method section of Chapter 3.  
 
(1.3) 
 
The closing equilibrium constant can be related to a term ‘protection factor (PF)’ given by, 
 
(1.4) 
 The protection factor reflects the physical environment of an amide that is correlated with the 
thermodynamic stability of the closed state [47]. Thus PF is an important parameter to estimate 
the conformational flexibility that can serve as thermodynamic sensor of local structural stability 
in any protein. This topic will be discussed in details in the data analysis section of Chapter 3. 
 
1.4.1.2 Deuterium Incorporation into Protein. Deuterium incorporation into protein can be 
done following two different strategies: pulse labeling and continuous labelling. Figure 1.8 
summarizes both approaches. Continuous labeling is performed by monitoring deuterium 
exchange rate at various incubation times under conditions where native conformation of protein 
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is stable. Therefore, approach provides information about conformational dynamics of native 
protein [20, 48, 49]. Complementary to this approach, pulse labeling involves labeling with 
deuterium for a very short time after the protein is forced to undergo structural changes where 
the incubation period with perturbing reagent is varied [50, 51]. The observed HDX profile is a 
snap shot of protein structure that exited at the time of pulse and provides information of the 
kinetics of the structural perturbation process. 
 
1.4.1.3 Measuring HDX with MS: Global Versus Local Exchange.  HDX experiments can be 
designed in two different manners depending on the goal of the studies. Deuterium uptake on the 
whole protein can be monitored to estimate the overall exchange behaviour which is known as 
Global exchange approach.  For site specific studies, proteins can be fragmented into smaller 
peptides to locate the local environment. Proteolytic digestion is relatively more versatile and 
popular approach (known as ‘bottom-up’ approach) which is usually followed by LC separation 
before mass analysis [52]. Alternatively, post ionization  gas phase ‘non-ergodic” fragmentation 
techniques like electron capture dissociation (ECD) or electron transfer dissociation (ETD) can 
provide near single residue resolved information but their usage is limited to the size of the 
protein (known as ‘top-down’ approach) [53-56].  
 
Site specific measurement of deuterium incorporation can be achieved by fragmentation 
of the intact protein either before ionization or post ionization gas phase fragmentation 
techniques. In either case the exchange reaction is quenched by lowering the pH at 2.5 prior to 
fragmentation to minimize the back exchange probability [57, 58]. Digestion of labeled protein 
can only be carried out using acid proteases typically with pepsin (usually porcine) that showed 
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the best performance for digestion under quench conditions [41, 57, 59]. To the date, two other 
acid proteases have been used either alone or in combination with pepsin: the type XII protease 
from Aspergillus saitoi and type XVIIIfrom Rhizopus sp., both of them are less efficient than 
pepsin [60].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. General work flow scheme for HDX-MS experiments.  
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1.4.1.4. HDX with Time Resolved Electrospray Ionization (TRESI). Time-Resolved 
Electrospray Ionization mass spectrometry (TRESI-MS) has been established as an 
extraordinarily enabling technology in the study of conformational changes occurring on the 
millisecond (ms) timescale during biological activity. TRESI-MS allows for the simultaneous 
detection of virtually all reactive species undergoing a reaction process which is almost always 
inaccessible via conventional optical based analytical techniques. The development of ESI MS 
enabled continuous-flow rapid mixing tool by Wilson and Konermann, made a breakthrough in 
time – resolved (TR) experimental techniques [61]. Their TR apparatus (Figure.1.9) is 
essentially a concentric capillary mixer with adjustable reaction chamber volume that can be 
used as an alternative ESI source.  Reactant solutions are continuously introduced to the mixer 
from both syringes while they are only allowed to mix in a narrow region towards the outlet of 
the device. This approach facilitates efficient diffusive mixing of reagents which initiates the 
reaction of interest. The reaction time can be controlled by changing the position of the mixer 
within the outer capillary or/and changing the flow rates. The reaction time associated with 
mixing is known as the ‘dead time’ and largely determines the earliest time point accessible by 
the apparatus.  The approximate reaction time can be calculated based on the total flow rate and 
reaction volume (Equation 1.5). 
t = Vr / vt + Vm / vt                          (1.5) 
 where, 
 t = reaction time  
 vt  =  total solution flow rate 
Vr = volume of the reaction chamber 
Vm = volume of the mixing region 
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Figure 1.9. Schematic depiction of a Capillary-based rapid mixer with adjustable reaction 
chamber volume for TRESI-MS. An inner fused silica capillary is inserted through an outer 
metal capillary of larger diameter through a three-way union. Two different solutions, one 
containing the protein and the second a deuterium donor, are supplied at the inlets of the 
capillaries by automated Hamilton syringes at rates maintaining laminar flow throughout the 
apparatus. A small notch, about 2 mm away from the plugged end of the inner capillary, enables 
the solution from the inner capillary to escape and mix rapidly with the solution in the outer 
capillary in the inter-capillary space. The region between the notch and the outlet of the 
apparatus at the end of the outer capillary represents the reaction chamber volume. The outer 
capillary is used as an ESI source. This figure is adapted from a reference [62]. 
 
 
TRESI-MS has contributed substantially to the characterization of short-lived 
intermediates involved in millisecond time-scale (bio)chemical processes. The aim of this 
research was to integrate more multistep MS- based experimental approaches (such as HDX, 
proteolysis) with TRESI in order to facilitate more detailed structural analysis of conformational 
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intermediates. This dissertation represents the successful integration of  TRESI with ‘bottom up’ 
HDX approach on a microfluidic platform enabling the characterization of  dynamic regions in 
native proteins and proteins undergoing conformational changes during biological activity which 
has been discussed in Chapter 3, 4, 5 and 6.   
 
1.5 MICROFLUIDICS 
 
Microfluidics (MF) is the science and technology of precise manipulation of fluids in 
networks of micro channels that can transport typically microliters to femtoliters volumes of 
fluid [63, 64].  This miniaturization technique has worked its way in many applications since it 
was first introduced in the beginning of the 1980s. Development of gas chromatography at 
Stanford by S.C. Terry in 1979 is a milestone in the history of MF. Soon after that, researchers at 
IBM developed ink jet printer nozzles less than 100 µm in diameter which is probably the most 
mature MF microfluidic technology that is prevailing in ink-jet printing industry for last 20 years 
[65-67].  
Microfluidic systems offer distinctive properties such as  
 Aqueous flow is generally laminar, not turbulent. 
 Diffusion is an efficient process for mixing the dissolved contents of two or more fluids. 
 Particles can be separated based on their size (by diffusion).   
 Compared with other analytical devices, microfluidic devices allows rapid reaction and 
analysis times [68].  
 Only small volumes of samples and reagents are required facilitating efficient heat and 
mass transfer.   
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 Allows the parallelization and integration of multiple sample processing approaches. 
 Produces little waste which is very important in working with biologically hazardous 
material [69]. 
 Facilitates the measurement of the reproducibility of biochemical (or more importantly, 
cell biological) experiments which involves a large number of parallel run experiments 
[70]. 
 
 Beyond that, microfluidic system offer several new advantages to carry out specialized 
types of biochemical synthesis. In contrast to traditional isolated application specific approaches, 
MF provides a set of fluidic unit operations which can be designed for automated multiple 
application chemical, biochemical or medical process. High throughput microfluidic systems 
have been applied as a powerful tool in different stages of variety of fields, including analytical 
chemistry, genomics, proteomics, drug discovery and delivery, diagnostics, combinatorial 
synthesis, single cell analysis, protein separation, crystallization, biosensing, and for a variety of 
laboratory automation applications in the pharmaceutical and healthcare industries [70, 71]. The 
scope of the applications of MF boundless as it offers fundamentally new capabilities for 
controlling concentrations of molecules in space and time [72]. The most important 
functionalities are sample preparation, mixing, transportation, separation and biosensing 
detection. The terms ‘lab on a chip’ (LOC) and Micro Total Analysis System (μTAS) are 
synonyms for devices that takes advantages of micro flow and integrate a multiple sample 
handling functionalities on a small scale on a single platform [63, 73]. Many complex chemical 
and biological systems require multidimensional analysis for identification and quantification of 
individual components but cannot afford to waste sample at various sample handling steps.  LOC 
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and μTAS support integration of a number of different surface geometries and chemistries to 
address this issue enabling direct analysis of many challenging and complex biological systems 
including whole cells, nucleic acids, proteins, enzymes. 
1.5.1 Fabrication Techniques and Materials  
The choice of appropriate material is important in application specific device development and 
should include considerations such as machinability and ease of fabrication, cost, process time, 
chemical compatibility, molecular adsorption, surface charge, optical properties. Glass, quartz, 
silicon, polymeric substrates like poly(dimethylsiloxane) (PDMS), poly(methyl methacrylate) 
(PMMA), polycarbonate, Teflon and many other elastomers or even metals like aluminum or 
copper have be used successfully to fabricate MF devices [74-78]. Conventional approaches in 
the fabrication of microfluidic devices includes photolithography, chemical etching, hot 
embossing, laser ablation, thin-film deposition, electroplating,  thermal or chemical bonding and 
bond breaking or formation using UV, chemical degradation [79]. Many of these commonly 
used fabrication protocols are lengthy requiring days to week from design to completion [80]. 
This work presents a simple and fast fabrication technique that uses laser ablation to generate 
microchannels on PMMA.  
 
1.5.2 The Microfluidic Environment and Mixing Principles. In microfluidics, the 
flow pattern is governed by channel geometry along with two important inherent properties of a 
fluid: surface tension and viscosity. When fluid passes through a micro channel, the molecules of 
the fluid in contact with the stationary solid surface tends to slow down due to the frictional 
resistance which is related to Reynolds number (Re). Conversely, the fluid at the center of the 
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stream experiences higher velocity which generates a distribution of flow velocities within the 
microfluidic channel [81, 82]. 
1.5.2.1 Reynolds Number (Re). In fluid mechanics, the effect of viscosity on flow 
characteristics is interpreted in terms of Reynolds number (Re). Re is the ratio of inertia forces to 
viscous forces that quantifies the relative importance of these two types of forces for given flow 
conditions. Systems that operate at the same Reynolds number will have the same flow 
characteristics even if the fluid, speed and characteristic lengths vary.  The general expression of 
the Reynolds number (Re) is  
                                                   (1.6) 
where,  
 
V = average velocity of flow 
L = a characteristic length  
μ = the viscosity of the fluid 
ρ = density of the fluid 
High values of the Re (on the order of 10 million) indicate that viscous forces are small and 
the flow is essentially having no boundary layers [83]. On the other hand, low values of the 
parameter (on the order of 1 hundred) indicate that viscous forces are dominating parameters 
influencing the fluid flow [83, 84]. The Reynolds number provides the criterion for Laminar and 
turbulent flows.  
1.5.2.2 Laminar Flow. Flows of fluid can be classified into variety of categories with 
consideration of the flow characteristics with respect to time and the distance along the flow 
path.  In 1883, Professor Osborne Reynolds of Manchester University classified fluid flow into 
two distinct types: Laminar and turbulent flow [85].  Laminar flow has a smooth appearance in 
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which flow occurs in layers with one gliding over the other with little or no mixing. Most 
viscous fluids flow under laminar regime having a distinct boundary layer. On the other hand, 
turbulent flow is characterized by mixing of fluids by eddies of varying size within the flow. 
Any fluid flow may be laminar providing it occurs at a small enough velocity or around 
microscopic dimensions when the Re number drops to around 2000 [63, 85]. However the 
transition between laminar and turbulent flow occurs between Re of 2300 - 4000 and this 
transition can be modulated by changing the flow velocity. Under a critical value of Re (Re ≤ 
2300), fluids follow unidirectional but steady parallel paths where only molecular diffusion may 
generate fine spread out between two layers [86, 87]. The typical channel depth used for this 
work is under 200 μm where the Re value is around 1 [73, 83, 88]. Therefore the fluid flows 
under our experimental conditions will be laminar flow. 
1.5.2.3 Mixing in Microfluidic Devices. Many of MF applications require mixing of two or 
more reagents which is often a challenging task under laminar flow condition. Diffusion can play 
a dominant role in microfluidic mixing while in macroscopic systems, mixing can be achieved 
through turbulent flow or vigorous stirring [89]. Reactions initiated in micro-sized systems that 
are strictly diffusion-limited occur significantly faster than they would at the larger scale. Mixing 
performance can be increased by increasing mixing time and contact surface so that the diffusion 
occurs efficiently. The diffusion time (td) increases proportionally with the diffusion length or 
diameter of the reactor but inversely with diffusion coefficient (D) which is shown in the 
following equation. 
td = d2 / D                             (1.7) 
Therefore, the diffusion coefficient (D) is a good approximation to evaluate the 
feasibility of diffusion limited mixing (as well as reaction) of multiple analytes in a micro 
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channel that rely solely on diffusion. Diffusion is also strongly influenced by nonreacting species 
or solvent molecules that need to be under consideration as well (solvent shells can contribute to 
the apparent D).  Since diffusion coefficient (D) is a measurement of how fast reagent molecules 
can move in a medium such as water, in a laminar flow system, molecules with a higher D value 
will travel faster into another layer and will ensure mixing of analytes [88]. Mixing of any large 
biomolecule with a small molecule under laminar condition is therefore has to rely on the 
diffusion of small molecules since the D values of biomolecules are usually very small (decrease 
with the increasing molecular size) [69, 90, 91]. Table 1.1 shows diffusion coefficients for small 
and large molecules in water [83]. 
Table 1.1. Diffusion coefficients for small and large molecules in water at 25 ºC 
 Molecule Molecular Weight /kg mol
-1
 D/10
-10
 m
2
s
-1
 
Proton  0.001  50 
Water 0.018 22.6 
Methanol 0.032 15.8 
Ethanol 0.046 12.4 
Sucrose 0.342 5.216 
Ribonuclease 13.7 1.19 
Urease 480 0.346 
Myosin 493 0.116 
Collagen 345 0.069 
 
All of the systems studied in this dissertation involve single or multiple mixing steps 
between protein molecules with aqueous acetic acid or deuterium oxide. Therefore, the mixing 
length and time was optimized experimentally to ensure complete diffusion of protons into 
protein layer. In most of the cases, internal standards were applied to adjust optimum diffusion 
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length and flow rates. When it occurred, poor mixing performance was evident in the mass 
spectrum, appearing as complicated and non-Gaussian deuterium distributions.  
 
1.5.3 VersaLASER.  In This work, we use a 30 watt carbon dioxide (CO2) laser for ablation of 
PMMA. Carbon dioxide (CO2) lasers convert 20% of the input power into laser light which is 
highly efficient  [92, 93]. Its operation can be initiated electronically under a variety of 
conditions, emitting a steady narrow beam at low gas pressure or pules at high pressure. Certain 
parameters such as mode,  wavelength, type of laser operation (continuous wave or pulsed) and 
focal length are fixed for selected laser and beam delivery system while only the laser power is 
varied to obtain a desired laser energy level. The CO2 laser has relatively low precision 
requirements but generates high power as it uses laser energy intensities between 20 kW/cm
2
 and 
60 kW/cm
2
 [92].  The CO2 laser is capable of generating an emission band between 9 and 11 μm 
in the infrared region which involves vibrational transitions of the CO2 molecule. But the 10 μm 
output is generally used as it can be transmitted through atmosphere efficiently and is absorbed 
strongly by a wide range of materials making CO2 lasers suitable for cutting, drilling and 
welding of metals and non-metals [93].  Presently the use of lasers is rapidly growing in modern 
industrial applications as new alternative to traditional manufacturing processes. 
 
 VersaLASER™ is a computer controlled CO2 laser device assisted by drawing software 
(i.e. CorelDraw X3) that is capable of transforming images or drawings into engravings on 
variety of materials. Materials such as plastics, woods, fabrics, metals, glass and ceramic can be 
effectively processed with a short production time around minutes depending on the complexity 
of the design. The drawing generated on the graphic software is color coded where blue denotes 
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for marking, red for cutting and black for deep engraving (raster). This laser system uses high 
quality digital motors with highly reliable and simple optical encoders to function as a printer at 
different laser power and mode. The laser can be focused manually based on material thickness, 
allowing precise control of channel width and depth which is extremely important for predicting 
the nature of the fluid flowing through this micro channels. 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. a) Universals VersaLASER™ b) a schematic representation of work process of 
versa laser.    
 
1.5.4 Poly(methyl methacrylate) PMMA. Poly(methyl methacrylate) (PMMA) is a synthetic 
polymer of methyl methacrylate with the trade name Plexiglas® or  acrylic glass. PMMA is a 
crystal clear thermoplastic material that can be used as an economical replacement of glass.  The 
exceptional characteristics of PMMA are its optical clarity, low UV sensitivity, good mechanical 
stability, surface hardness and excellent resistance to aging and weather including UV radiation. 
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PMMA has good antiscratch properties and retains its gloss coating even after prolonged use; 
however it is susceptible to cracking under tensile stress. Despite of its superb environmental 
stability, PMMA demonstrates poor solvent resistance to many organic solvents on an account of 
its easily hydrolyzed ester groups. Therefore any scientific application that involves PMMA is 
limited to a narrow solvent choice [94]. PMMA swells and eventually dissolves in any 
inappropriate solvent which may interfere with reagents used in experiments and cause excessive 
background noise in mass spectra. 
PMMA is often preferred in microfluidic device fabrication because of it is moderate 
properties, easy handling and low cost [80].  In recent years, CO2 lasers have been used to for 
engraving micro channels on PMMA as it absorbs IR light in 2.8- 25 μm wavelength band which 
is compatible with CO2 lasers [74, 95].  PMMA vaporizes to gaseous compounds including its 
monomers upon laser ablation ensuring very clean and fine channel formation. As PMMA is an 
organic polymer, release of its monomer vapour to environment upon laser cutting does not 
cause pollution. This ablation process is implemented not only in microfluidic device fabrication 
but also in visual communication food-contact applications and the medical sector.   
 PMMA is the most frequently used material in microfluidic research because of its other 
advantages in terms of faster design times, low cost, possibilities of obtaining flexibility 
deformable shapes and the ability to seamlessly impregnate nanoscale features [75, 95, 96]. In 
this work, PMMA was chosen as a substrate for MF device fabrication using laser ablation 
mainly because of its faster process time and low cost. The fabrication process is discussed in 
details in experimental section of Chapter 2.  
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CHAPTER 2 
 
A Versatile Microfluidic Chip for Millisecond Time-scale Kinetic Studies by 
Electrospray Mass Spectrometry 
Adapted from J. Am. Soc. Mass Spectr. 20 (1): 124-130 
 
2.1 INTRODUCTION 
 
  Microfluidics involves the fabrication of micro-scale features, usually in glass [1-
3] or polymer substrates [4, 5], to enable the precise handling of small volume liquid samples. 
Micro-scale liquid handling facilitates mass and heat transfer, reduced sample consumption and 
high throughput via parallelization while minimizing sample loss and cross contamination [6-8]. 
Virtually any laboratory process involving fluid handling can be miniaturized to capitalize on 
these advantages. There is therefore widespread interest in the development of modular ‘lab on a 
chip’ devices with integrated sample preparation, separation and reactor functionality [9]. There 
are a number of options for ‘on-chip’ analysis including sensors that are optically [10-12], 
electrically [13, 14] or even mechanically based [15].  
 
 While technically ‘off-chip’, ESI-MS is effectively an ‘on-chip’ analysis if it is initiated 
directly from the microfluidic channel outlet [16-18]. Generation of stable ESI signals from the 
outlets of microfluidic devices is challenging. Contact between liquid expelled from the outlet 
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and the edge of the chip typically results in large, unstable Taylor cones. Several approaches 
have been devised to improve signal stability in ‘on-chip’ ESI experiments including the 
integration of hydrophobic membranes [19] or porous polymer monoliths [20] at the channel 
outlet. The simplest approach is to limit the eluent/chip contact surface area by spraying from the 
corner of the chip or by tapering the outlet [16]. 
  
ESI Coupled Microfluidic Devices (ECMDs) have been devised for numerous 
applications, particularly in the area of proteomics [8]. The complimentary advantages of 
microfluidic liquid handling and ESI-MS based analysis make these devices a natural answer to 
the challenges of proteomic studies. Apart applications in the area of proteomics, however, the 
vast potential of ECMDs remains largely untapped. One ‘underrepresented’ application is rapid 
microfluidic mixing for time-resolved studies by ESI-MS [16, 21].  
  
Time-resolved electrospray ionization Mass Spectrometry (TR ESI-MS) is a powerful 
approach for the characterization of short-lived, ‘transient’ intermediates in biochemical 
reactions [22-29].  Transient intermediates are critical to the biological activity of proteins, from 
enzymatic reactions [26, 30] to protein folding [31, 32], and are therefore potential targets for 
rational drug design. The transient adoption of partially unfolded conformations is also a factor 
in pathogenic protein aggregation, amyloidosis, which is associated with a number of human 
diseases including Alzheimer’s, Parkinson’s and Creutzfeldt-Jacob disease [33, 34].  By TR  
ESI-MS, transient protein folding species are identified by their charge-state distribution [35] or 
(with an additional mixing step) by their hydrogen/deuterium exchange (HDX) profile [36]. 
Transient covalent or non-covalent modifications are detected as mass shifts in the protein 
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molecular ion corresponding the mass of the binding partner [23]. This represents considerably 
more detail than what can typically be acquired in conventional optical time-resolved studies, 
and the analysis does not require artificial chromophoric labels. 
 In order for TR ESI-MS to present a viable alternative to optical time-resolved methods, 
however, it must be possible to acquire complete a reaction time-courses in a single experiment. 
This motivated the development of ‘Stopped Flow ESI-MS’ by Kolakowski and Konermann in 
2000 [28, 29]. In 2003, Wilson and Konermann introduced a continuous flow capillary mixer for 
TR ESI-MS that facilitated full time-course acquisitions on time-scales comparable to optical 
stopped flow experiments [22]. This approach has enabled numerous investigations [22-24, 35-
38], but the concentric capillary design is limiting in terms of reproducibility of fabrication and 
is not well suited to the inclusion of directly coupled sample preparation or separation steps. 
  
This work introduces a new microfluidic device for TR ESI-MS. The device incorporates 
an internal capillary mixer that is similar to the one in reference [22], but formed by laser 
ablation with greatly improved reproducibility. The microfluidic design is simple, involving two 
intersecting channels, two inlets and a tapered outlet for stable, low dead-volume ‘on-chip’ ESI. 
Fabrication is fast, straightforward, reproducible and inexpensive. Device performance is 
characterized by monitoring acid induced cytochrome c unfolding kinetics, in the course of 
which a previously unreported intermediate is detected. To enable the extraction of reliable rate 
constants, a theoretical framework for the analysis of kinetic data acquired under laminar flow in 
a square channel is devised. 
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2.2 EXPERIMENTAL 
 
2.2.1 Chemicals and Supplies. Horse heart cytochrome c was purchased from Sigma (St. Louis, 
MO). Ultrapure water was generated in-house on a Millipore Milli-Q Advantage A10 system. 
High purity acetic acid (99.7+ %) was purchased from Sigma. Blank PMMA substrates with 
dimension (l = 8.9 cm, w = 3.8 cm, h = 0.3 cm) were supplied by Professional Plastics 
(Fullerton, CA). Polyimide coated glass capillaries (O.D. 153 m, I.D. 75 m) were supplied by 
Polymicro Technologies (Pheonix, AZ). Metal capillaries (O.D. 400 m, I.D. 200 m) were 
from Small Parts, Inc. (Miramar, FL). PTFE tubing (O.D. 1/16″, I.D. 400 m) was purchased 
from McMaster Plastics (Scarborough, ON). Standard 1/16″ fittings were supplied by Upchurch 
(Oak Harbour, WA). 
 
2.2.2 Microfluidic Device Fabrication. The microfluidic reactor was fabricated using a 
VersaLaser™ engraving device (Universal Laser, Scottsdale, AZ). The microfluidic channel 
design was generated in CorelDraw X3 (Corel, Ottawa, ON). Laser power and mode were 
differentiated by color (red = vector mode cutting, blue = vector mode marking, black = raster 
mode). Microfluidic channel widths were adjusted to 155 m ± 2 by slightly defocusing the 
laser. The channels were engraved into blank PMMA substrate to a depth of 155 m ± 2 using 
two vector marking runs at 2.2 J/cm2. The distal end of the device was cut to a sharp tip using 
vector cutting mode at 4.6 J/cm2. At the proximal end of the device, channels were connected to 
external 1/16″ Upchurch fittings by using thin-walled metal capillaries as ‘step up’ unions. The 
metal capillaries were melted into the channel inlets at one end and pressure fit into 1/16″ O.D. 
PTFE tubing at the other.  A second blank PMMA substrate was used as the cover. The chip and 
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cover were placed in a vice (~5 MPa) and thermally bonded in a convection oven (120 °C for 40 
min).  Fluids were introduced into the device using Harvard 11+ infusion pumps (Holliston, 
MA). Typical flow rates were 7.0 L/min for both reactants. A picture of the device is shown in 
Figure 2.1A. The main microfluidic channel was sized to accommodate a 153 m O.D. fused 
silica ‘mixing capillary’. The distal end of the capillary was sealed with molten fused silica by 
cutting at high laser power. Vector marking mode (+7%) was used to cut a notch in the capillary 
2 mm from the sealed end. A microscopic view of the mixer inside the main microfluidic 
channel is provided in Figure 2.1B. Fluid passing through the capillary exits through the notch 
and is forced into the narrow space between the capillary and the channel walls. Here it mixes 
with fluid that has passed through the channel around the inner capillary. The observed reaction 
time is adjusted by changing the position of the mixing capillary within the channel. Early 
reaction times are observed when the mixer is positioned close to the ESI outlet. Steadily 
distancing the mixer from the ESI outlet yields mass spectra corresponding to steadily later 
reaction times. 
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Figure 2.1. A macroscopic view of the reactor is shown in panel A. The main channel runs the 
length of the device and accommodates a 153 m O.D. fused silica ‘mixing capillary’. A second 
channel delivers fluid into the main channel and around the mixing capillary. Panel B provides a 
microscopic view of the distal end of the mixing capillary within the main channel. The total 
volume of the mixing region is ~ 10 nL. Moving the mixing capillary within the main channel 
changes the reaction volume and thus the delay between mixing and ESI. 
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2.2.3 TR ESI-MS experiments. Time-resolved mass spectrometry was carried out on a QStar 
Elite Q-TOF instrument (MDS Analytical Technologies, Concord, ON) with an in-house built 
source assembly. The source recognition logic was circumvented using a custom switch. The 
instrument was operated in positive ion mode with source voltage +5500 V and moderate 
declustering conditions (Declustering potential (DP) = 60 – 90 V, Focusing Ring (FP) = 200 – 
250 V). In a typical kinetic run, the distal end of the mixing capillary was initially positioned at 
the ESI outlet of the main microfluidic channel. The solution passing through the mixing 
capillary was 10 M cytochrome c in ultrapure water. The solution passing around the mixing 
capillary was 10% (v/v) acetic acid in ultrapure water. Both solutions were injected at a rate of 7 
L/min. Kinetics were measured by withdrawing the mixing capillary at a rate of 2.0 x 10-4 m/s 
such that the reaction volume (the volume between the end of the mixing capillary and the ESI 
outlet) increased at a rate of 0.3 L/min. As the mixing capillary was withdrawn, full ESI mass 
spectra were acquired at a rate of 1 s-1. This corresponds to a mass spectrum every 20 ms of 
reaction time. However, the relationship between delay volume and analyte age is complicated 
by laminar flow as discussed in the theory and data analysis section. 
 
 
2.3 THEORY and DATA ANALYSIS 
 
2.3.1 Laminar Flow in a Square Channel. At ESI-compatible flow rates, flow through 
microfluidic channels is laminar. Square channel laminar flow is characterized by a 3 
dimensional parabolic velocity profile (Figure 2.2).  
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Figure 2.2. A model of the laminar flow velocity profile within the reaction channel, based on 
expression (2.1). Solid lines represent contours with constant velocity. The radially asymmetric 
shape of the contours emphasizes that rectangular channel velocity profiles cannot be accurately 
approximated by assuming a circular geometry. 
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The general expression for the velocity profile in a rectangular channel is given by [39]: 
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Equation (2.1) uses a Cartesian coordinate system whose origin is at the center of the channel.  X 
and Y are the distances from the center of the channel to the wall in the width and height 
dimensions, respectively (i.e. X = ½ channel width, Y = ½ channel height). The coordinates x and 
y can therefore have values in the ranges –X..X and –Y..Y. The exponents nx and ny are calculated 
from the aspect ratio of the channel,  = height/width. For  ≥ ⅓, nx = 2 + 0.3(-⅓) and ny = 1.7 
+ 0.5-1.4 [39]. In the present case, the channel is square, such that nx = ny = 2.2. The maximum 
flow velocity vmax can be calculated from the average flow velocity vavg by: 
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The laminar flow velocity profile convolutes our kinetic data; analytes occupying the 
center of the channel will be ‘younger’ when they arrive at the ESI source than analytes near the 
channel walls. To account for this, we can derive a probability distribution function P(a) that 
gives the probability of detecting an analyte of age a for a given reaction channel length l. 
Combining P(a) with an expression for analyte concentration as a function of age C(a) and 
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integrating from a = l/vmax to a = ∞, gives the average concentration of analyte at the ESI outlet 
Cavg, which is assumed to be proportional to the ESI signal intensity [40]:  
 
    daaCaPC
vl
avg )()(
max/
      (2.3) 
 
This approach for analyzing kinetic data acquired under laminar flow conditions was introduced 
by Konermann in 1999 [40]. However, in that work P(a) was derived for a circular geometry. In 
a circular tube, the laminar flow velocity profile is radially symmetric and therefore dependent 
on a single geometric parameter r (distance from the tube center). In a rectangular channel, the 
velocity profile is a function of both x and y. We must therefore use a different approach to 
calculate P(a). 
 
 For a given l, we can define a function G(a0) that gives the total number of particles with 
velocity v ≥ l/a0 (age a  a0) passing through the detector per unit time: 
 
       bb bbyy xx dxdyyxvaG ),()( 0      (2.4) 
 
The constant  represents an analyte concentration factor. To simplify the integral, we can take 
advantage of the x and y axis symmetry of v(x,y) and restrict our derivation to the +x, +y 
quadrant. The range of x and y is thereby constrained to x = 0..X and y = 0..Y and the expression 
is multiplied by 4. An additional simplification for square channels is that X=Y and nx = ny. 
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Incorporating these simplifications, and using the condition v ≥ l/a0, the upper limits of 
integration are: 
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And expression (2.4) becomes: 
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Using the limits yb and xb, expression (2.6) defines a cross sectional area of v(x, y) bounded by 
the velocity contour v = l/a0 . The expression can be integrated analytically in one dimension, but 
the resulting integral must be solved numerically for most cases of a0.  
 
 From expression (2.6), it is evident that the fraction of analyte passing through the 
detector within the area bounded by G(a0) is G(a0)/G(a0=∞). This fraction can also be defined as 
the probability of detecting an analyte with age a  a0. It follows, therefore, that the probability 
of detecting an analyte with a particular age, P(a) is:  
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where a is the width of the age interval.  Note that calculations of P(a) become more accurate 
as a  0.  Figure 2.3 plots P(a) for several reaction channel lengths. P(a) can now be 
substituted into Equation (2.3) for ‘square channel laminar flow corrected’ analysis of the kinetic 
data. This derivation of P(a) is more general than those developed previously. It can be used for 
any channel geometry provided that there is at least one axis of symmetry. 
 
2.3.2 Other considerations. The analytical framework introduced above applies only to a fully 
realized laminar flow. Laminar flow develops over an entrance length lent that is easily 
approximated for a rectangular geometry; lent ≈ 2.4 A/P where A and P are the area and perimeter 
the perimeter of the microfluidic channel [41]. In the present study, lent = 4.5  10-5 m, less than 
1/5 the shortest l used (2.0  10-4 m). We therefore consider the effects of lent on the kinetic data 
to be negligible. Data analysis might also be convoluted by Taylor dispersion-based distortion of 
the laminar flow velocity profile. However, on the scale of the reaction channel (155 m  155 
m), significant distortion of the laminar flow profile occurs on the order of seconds [22], much 
longer than the timescale of our kinetic experiments (final time point = 0.65 sec). The effects of 
Taylor dispersion can therefore also be neglected. 
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Figure 2.3 A probability density P(a, l) giving the probability of detecting particles of particular 
ages at various reaction channel lengths. In expression (2.3), P(a) is combined with a function 
describing changing concentration as a function of age due to the reaction, C(a), to give a 
laminar flow corrected time-dependent ESI signal intensities. 
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2.4 RESULTS AND DISCUSSIONS 
 
2.4.1 Fabrication. One of the aims of this work was to devise fast, simple and reproducible 
protocol for Electrospray coupled microfluidic device (ECMD) fabrication. Conventional 
approaches for the fabrication of  ECMDs include photolithography [42, 43] and polymer 
imprint techniques [20, 44]. Elegant, highly detailed microscale features can be generated using 
these methods, but they require specialized facilities, equipment and expertise. While efforts are 
being made to simplify photolithographic and polymer imprint fabrication [43], most protocols 
still require days to go from design to completion. In the present study, microchannels and the 
microfluidic mixer were formed by laser ablation using an inexpensive VersaLaser™ engraving 
device.  
 
 Laser ablation has some disadvantages relative to other microfabrication techniques. 
Firstly, the generation of ultrafine features is limited by the dot size of the laser and thermal 
conduction causing melting around the laser dot. Equipped with high resolution optics, the 
engraving device used in the present study can generate a dot size of ~ 15 m, which, in PMMA, 
corresponds to a minimum feature size of ~ 30 m. Since the microfluidic reactor is composed 
of features that are much larger than this (155 m), the standard resolution optics were sufficient. 
Secondly, microfluidic channels generated by laser ablation are not perfectly rectangular, but 
rounded at their base. The extent of this effect depends on a number of factors including the 
quality of laser and optics used, but always increases with the aspect ratio . We found that the 
VersaLaser™ could generate an essentially rectangular channel in PMMA up to  ≈ 1.3, which 
is well above our requirements ( = 1). 
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The main advantage of our fabrication approach is that it is exceedingly straightforward. 
In this study, designs were generated using widely available illustration software (CorelDraw 
X3) and then simply ‘printed’ onto the PMMA substrate. The fabrication process therefore 
requires no specialized expertise or facility. The production cycle is also extremely rapid. 
Prototypes of the microfluidic reactor generally required < 2.5 hours from design to completion. 
 
2.4.2 Mixing. In time-resolved experiments, mixing is almost always the main contributor to 
dead-time. The design of efficient mixers is a major branch of microfluidics research [45-47]. 
Approaches such as hydrodynamic focusing or the generation of chaotic flow can result in 
extremely efficient mixing on the micro-scale [16, 45, 47]. The microfluidic reactor introduced 
in the present study incorporates a mixer that is integrated into the distal end of the mixing 
capillary (Figure 2.3). The mixer operates by forcing reactant solutions to flow together through 
the narrow space between the mixing capillary and the channel walls. Since this space is defined 
by a round capillary tightly fit into a square channel, the minimum mixing efficiency occurs at 
the corners where the distance between the capillary and the channel walls is ~ 65 m. For a 
mixer length of 2 mm, the total volume of the mixing region is ~ 10 nL. This corresponds to an 
average mixing time of ~ 43 ms in our experiments.  
  
Given the complications of flow within the mixer (i.e. complex geometry, a developing 
laminar flow profile etc.) it is not feasible to devise a theoretical model to predict mixing 
efficiency. However an estimate of diffusion length, LD = (4Dt)1/2 where D is the diffusion 
coefficient of protons in bulk water (~110-8 m2s-1) [48], gives an average distance of 41.5 m in 
43 ms. Therefore, assuming that the laminar flow layer containing excess protons occupies half 
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of the distance from the capillary to the channel wall, it is not unreasonable to expect complete 
equilibration of proton concentration within the mixer based on diffusion alone. Furthermore, 
massive rearrangement of the laminar flow profile upon the incorporation of fluid exiting the 
notch may significantly enhance mixing efficiency [49]. 
 
 Mixing efficiency was gauged experimentally by changing the length of the mixer and 
monitoring the effects on the measured cytochrome c unfolding kinetics. It was observed that 
when the notch was positioned between 0.5 and 1.5 mm from the end of the mixing capillary, a 
fraction of the folded protein population did not undergo rapid unfolding, but rather decreased 
slowly and linearly as a function of time (data not shown). Both the magnitude of this persistent 
folded population, and the rate at which it was eliminated, were dependent on mixer length. This 
is exactly the result expected if mixing is incomplete upon transfer to the reaction channel. 
Unmixed fluid passing into the reaction channel will form a laminar flow layer within which 
native conditions persist. This layer will slowly be eliminated via inefficient diffusive mixing 
with surrounding flow layers. Ultimately, it was determined that a mixer length of 2 mm was 
required for complete mixing prior to transfer into the reaction channel. 
 
 
2.4.3 On-Chip Electrospray and Instrument Dead-time. The two main considerations for TR 
ESI-MS experiments with respect to electrospray performance are Taylor cone volume and 
stability. Taylor cone volume is especially significant because it contributes to the dead-time of 
the experiment. Taylor cones generated ‘on-chip’ tend to be larger than those produced at 
conventional capillary outlets due to interactions between the eluent and the edge of the substrate 
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[50]. In this respect, the use of PMMA, which is quite hydrophilic, is disadvantageous. In the 
present study, an effort was made to reduce spreading by tapering the ESI outlet to a sharp point. 
In addition, source potentials were at least 300 V higher than the minimum required to generate a 
stable Taylor cone. From scaled pictures taken on a CCD camera (Figure 2.4A), and assuming a 
radially symmetric shape, Taylor cone volumes were estimated to be in the range of 1 – 3 nL, 
corresponding to 4 – 12 ms of dead-time at 14 L/min. The dead-time of the microfluidic reactor 
was therefore 43 ms (mixing) + 12 ms (taylor cone) + 1 ms (desolvation [51]) ≈ 56 ms. 
 
 Taylor cone stability is the dominant factor affecting variability in ESI signal intensity. In 
TR ESI-MS experiments, Taylor cone instability results in noisy and in extreme cases un-
interpretable kinetic data. Signal stability for ECMDs with ‘on-chip’ ESI is generally lower than 
that of capillary-based devices and the present microfluidic reactor is no exception. Figure 2.4B 
shows a typical TIC of 5 M cytochrome c in 5% (v/v) acetic acid at a reaction time of 250 ms 
(roughly halfway through the unfolding process). Over 5 minutes of data collection, the standard 
deviation for TIC signal intensity was 5,219 or 2.8%. This degree of signal stability was more 
than sufficient to provide reliable kinetic data. 
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Figure 2.4. Panel A shows a representative image from a series of images used to estimate 
Taylor cone volume. The ESI outlet of the device was ~ 4 mm from the curtain plate (digitally 
removed from the image) which was held at -1000 V. Source potential was +5500 V. A stable 
Taylor cone was observed at a source potential of +5250 V under these conditions. Panel B 
shows the TIC for a 5 M solution of cytochrome c in 5% acetic acid. The mixing capillary was 
positioned to allow 250 ms of reaction time. Source conditions were the same as panel A. The 
signal has a standard deviation of 5219 or 2.8%. 
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2.4.4 Cytochrome c Unfolding. Cytochrome c is a small heme protein from the inner membrane 
of the mitochondrion. In comparison to other proteins, the biophysical properties of cytochrome 
c have been extensively characterized [31, 52-56]. Cytochrome c is highly amenable to ESI, 
making it a convenient test subject for new MS-based analytical approaches [57-60]. The folding 
kinetics of cytochrome c are well studied [61] and were among the first processes to be 
investigated by time-resolved ESI-MS [25]. Kinetic cytochrome c unfolding studies are less 
common, possibly due to the assumption that transient intermediates will not become populated 
under strongly denaturing conditions and that therefore unfolding will be mechanistically 
uninteresting [62]. Kinetic unfolding intermediates of cytochrome c have been detected in 
optical studies, however [55, 63]. 
 
 Acid induced cytochrome c unfolding was used to gauge the effectiveness of our 
microfluidic reactor for monitoring millisecond time-scale kinetics. The reactor was first 
operated in ‘spectral mode’ in which the mixer is fixed at various positions within the main 
channel. Spectral mode allows the reaction to be monitored indefinitely at fixed time-points, 
facilitating the acquisition of high signal-to-noise mass spectra. Figure 2.5 shows mass spectra 
corresponding to cytochrome c unfolding at 70 ms (A), 200 ms (B) and 650 ms (C). Between 70 
ms and 200 ms, there is a shift in the dominant charge state from 8+ to 9+, suggesting the 
involvement of a partially unfolded, ‘native-like’ intermediate in the unfolding process. The 
transition from the intermediate to the unfolded protein appears to occur in a single step. 
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Figure 2.5. TR ESI mass spectra of kinetic cytochrome c unfolding at 70 ms, 200 ms and 650 
ms. Conditions after mixing were 5 M cytochrome c in 5% (v/v) acetic acid. A rapid transition 
was observed from a folded form of the protein with dominant charge state 8+ to an unfolding 
intermediate with dominant charge state 9+. The transition from 9+ to a broad distribution 
centered on 16+ occurred over a longer time-frame.  
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A more detailed analysis can be carried out in ‘kinetics mode’ where the mixing capillary 
is steadily withdrawn while mass spectra are collected. Figure 2.6 shows the results of a typical 
kinetics mode experiment. Each trace represents the ion current for peaks corresponding to 
various charge states of cytochrome c from 7+ to 19+. The observed kinetics can be roughly 
subdivided into three categories: Charge states 7+ and 8+ undergo monophasic exponential 
decay. Charge states 9+ and 10+ exhibit classic intermediate kinetics i.e. an exponential rise 
followed by an exponential decay. The intensities of charge states 11+ - 18+ increase 
exponentially after a brief delay.  
 
 The data were fit to expression (2.3) using a FORTRAN program developed previously 
[22] adjusted for square channel laminar flow as described in theory section. Fits are shown as 
solid lines in Figure 2.6.  The data were analyzed using an implicit global analysis strategy based 
on that in reference [35]. The concentration vs. time dependences for each cytochrome c charge 
state, C(a, m/z), were assumed to correspond to a sum of exponentials plus an offset. It was 
found that two exponentials were sufficient to obtain satisfactory fits to all of the kinetic data. 
The first exponential, associated with the formation of the intermediate, had a rate constant k1obs 
= 32 s-1 ± 5. This is in agreement with stopped-flow fluorescence data acquired by Bhuyan et al. 
[56] in 3.1 M GdnHCl, although it is difficult to make a direct comparison given the significantly 
different conditions employed in that study. The second exponential is associated with the 
transition from the intermediate to the ‘unfolded’ protein. This process was found to occur at 
k2obs = 7.5 s-1 ± 0.1. This rate agrees with the slow unfolding phase observed by Bhuyan et al. by 
stopped flow far UV-CD [56]. 
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Figure 2.6. A global view of cytochrome c unfolding kinetics. Charge state 7+ intensities have 
been multiplied by a factor of 5 to improve visibility. Charge states which do not provide reliable 
kinetics due to low signal-to-noise are excluded. Solid lines represent fits to the data using 
expression (2.3). P(a) was calculated as described in the theory section. In keeping with a global 
analysis strategy described previously [35], C(a) was assumed to have the form of a linear 
combination of exponentials plus an offset. Satisfactory fits to all of the kinetic data were 
acquired using 2 exponentials with rate constants k1obs = 32 s-1 ± 5 and k2obs = 7.5 ± .1 s-1. 
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 While folding intermediates are quite common  [32, 52, 64], unfolding intermediates are 
less commonly detected, particularly in a small proteins [35, 62]. Cytochrome c may be an 
exception due to its covalently bound heme which could act as a structural nucleus during 
unfolding. Alternatively, the complex unfolding landscapes predicted by some computer models 
[65] and observed for large proteins  [35]  may apply equally to small proteins. The microfluidic 
reactor introduced here can help to shed light on this question by facilitating the detection of 
transient unfolding intermediates, especially those that cannot be observed by conventional 
optical methods. However, the current charge state distribution-based analysis provides little 
information as to the nature of those intermediates. More detailed characterizations will be 
possible with the inclusion of additional microfluidic modules for H/D exchange pulse labeling 
and on-chip proteolytic digestion. 
 
2.5 CONCLUSIONS 
 
 We have introduced an ESI-coupled microfluidic reactor for millisecond time-scale 
studies by ESI-MS. The device was fabricated using a laser ablation-based approach that is fast, 
inexpensive and exceedingly straightforward. The reactor compares favorably in terms of 
performance with a capillary mixing system introduced previously [22] and will allow the 
incorporation of additional microfluidic modules downstream of the reactor. In a test study, the 
device provided a ‘global view’ of cytochrome c unfolding that included the detection of a 
transient unfolding intermediate. The data were fit using an approach that compensates for the 
effects of laminar flow on the observed kinetics. Rates in excess of 30 s-1 were reliably 
measured. 
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 While the device introduced in the present study is suitable for a broad range of 
applications, there are a number of improvements that will pursued in future work. One major 
issue is the significant mixing time, which results primarily from the accommodation of a round 
capillary into a square channel. We are currently redesigning the device to incorporate square 
capillaries, which have recently become commercially available. Since the ‘square in a square’ 
geometry will also improve mixing efficiency, mixing dead-times may be reduced to below the 
contribution from Taylor cone volume. Additional design changes are underway to reduce 
Taylor cone volume and increase Taylor cone stability by using thinner substrates and 
optimizing the tapering method. Design improvements are being undertaken in tandem with the 
development of multi-module ECMDs. Applications include measuring enzyme kinetics under 
native salt conditions and detailed characterizations of transient species in protein folding and 
enzyme reactions. 
 In summary, the microfluidic reactor introduced here provides the capability for 
millisecond time-scale studies by ESI-MS on a microfluidic platform. While the device 
represents a powerful and versatile tool in itself, it can also be incorporated into an integrated 
microfluidic ‘lab on a chip’.  
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CHAPTER 3 
Measuring Dynamics in Weakly Structured Regions of Proteins Using 
Microfluidics-Enabled Sub-second H/D Exchange Mass Spectrometry 
Adapted from  Anal. Chem., 84 (8),  3771-3779 
 
3.1 INTRODUCTION  
The tools of structural biology (i.e., X-ray crystallography and structural NMR) provide 
an exquisitely detailed, but largely static view of the physiologically relevant, ‘native’ structures 
of proteins [1, 2]. The importance of these structures to understanding how proteins carry out 
their biological roles cannot be overstated, and yet if proteins were to adopt only the structures 
reported, many would be essentially non-functional [3]. Virtually all aspects of protein activity, 
from catalysis to ligand binding and allostery depend on the ability to transiently adopt specific 
higher energy structures [4-8]. These ‘excited states’ are critical to function, and can in some 
cases act as a gateway to misfolding and disease [9-12]. Thus, there is substantial motivation to 
understand not only the ‘ensemble averaged’ structures revealed by classical structural biology, 
but also to characterize the transient, weakly populated structures that are adopted via 
conformational dynamics. 
 
Excited protein states are challenging analytical targets because they are i) transient, ii) 
weakly populated at equilibrium and iii) spectroscopically similar to the ground-state. In the 
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early 1980’s, backbone amide HDX was introduced as a means of measuring the integrity of 
hydrogen bonding networks in protein secondary structures, first by NMR [13] and later by mass 
spectrometry [14]. This approach is founded on the premise that solvent accessible backbone 
amide protons are protected from exchange with solvent if they are hydrogen bonded (as they are 
in secondary structures). The degree of protection reflects the strength of the hydrogen bond, 
and, averaging over adjacent amides, the stability of the secondary structure in question [15]. 
  
In NMR experiments, HDX is usually measured as a time-dependent decrease in the 
volume of backbone amide proton HSQC cross-peaks [13]. NMR measurements are always site 
specific, but transverse relaxation limits conventional solution NMR experiments to proteins < 
~50 kDa, and acquisitions are typically on the minutes time scale, which severely limits the 
ability to monitor more dynamic regions [16]. In MS-based HDX experiments, exchange is 
monitored via the mass increase accompanying deuterium uptake. This approach is more 
amenable to time-resolved measurements and need not be size limited, but usually provides 
‘segment averaged’ HDX data [17]. 
 
 MS-based HDX methods can be divided into ‘top-down’ and ‘bottom-up’ approaches. 
Top-down experiments involve fragmentation of deuterium-labeled protein ions in the gas phase 
(i.e. post-ionization) [18]. Top down experiments can yield single-residue resolution, but the 
electron capture/transfer fragmentation methods that are used (to avoid ‘scrambling’) [19-21] 
require more specialized equipment and impose an effective size limit [5] due in part to 
decreasing fragmentation efficiency with increasing size. The ‘bottom-up’ approach involves 
quenching of the HDX reaction by acidification, followed by proteolytic digestion using an acid-
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resistant protease [14]. In this case, spatial resolution is a function of digestion efficiency and 
typically ranges from 4 to 10 residues [22]. Thus, bottom-up HDX experiments yield ‘segment 
averaged’ data which are semi-quantitative. The advantage of the bottom-up approach is that it is 
broadly applicable; there is no inherent size limit and it can be carried out using widely 
available, non-specialized instrumentation. 
 
 One of the challenges of implementing bottom-up HDX is the occurrence of back-
exchange during the proteolytic and LC steps, which are carried out in H2O. Back-exchange not 
only dampens the structural information acquired during forward-labeling, it also does so in a 
site-specific manner that is governed more-or-less exclusively by the primary sequence (in 
contrast to the forward-exchange step, which is also structure dependent) [23]. Thus, significant 
back-exchange can lead to an artifactual deuteration ‘profile’ that is more reflective of the 
intrinsic back-exchange rates than conformational dynamics. Back-exchange can usually be kept 
to manageable levels by lowering the solvent pH to ~2.5 and the temperature to 0˚C, but 
sacrifices to digestion and/or separation efficiency are frequently made to avoid lengthy on-
column times [24].  
 
 In a typical backbone-amide HDX experiment, exchange is measured over a period of 
minutes-to-hours [22, 25, 26]. This timescale is appropriate for structured region of the protein 
because, while dynamics and the accompanying fluctuations between a hydrogen bonded 
‘closed’ state and an unbonded ‘open’ state may be rapid, the equilibrium Kop will strongly favor 
the ‘closed’ state, greatly slowing the observed rate of exchange. In more dynamic regions such 
as loops and weak secondary structures, however, conventional HDX measurements yield only a 
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‘burst-phase’ of exchange which, especially in loops, is commonly 100%. This limitation is 
unfortunate given the critical role that dynamic regions often play in protein function, and the 
biological importance of ‘intrinsically disordered’ proteins, which are largely dynamic in their 
native state.  
 
 In this work, we introduce a microfluidic device that enables time-resolved (i.e., 
millisecond time-scale) MS-based HDX measurements, integrating all of the necessary 
components for a bottom-up workflow with on-line ESI. This approach provides a powerful 
alternative to quench-flow experiments [27, 28], which are limited by decoupled sample 
handling and analysis and CLEANEX NMR [29, 30], which shares size and time-scale 
restrictions with other NMR methods. Residence times in the device are small relative to other 
techniques, ensuring minimal back-exchange ( 5%) without the necessity for cooling. Our 
present aim is to characterize device performance and to illustrate the utility of time-resolved 
HDX experiments. Three model systems are investigated including a single time-point structural 
analysis of ubiquitin, a comparison of loop dynamics in cytochrome c and a localization of 
conformational flexibility in the substrate-free form of a large tetrameric enzyme, DAHP 
synthase. 
 
 
 
 
 
 
76 
 
3.2 EXPERIMENTAL 
 
3.2.1 Materials. Horse heart cytochrome c, ubiquitin, pepsin, deuterium oxide (D2O), 
ammonium hydroxide, ammonium acetate (99.8%), 2-propanol (70% in water) and high purity 
acetic acid ( 99.7%) were purchased from Sigma (St. Louis, MO). Polyimide coated glass 
capillaries (O.D. 153 m, I.D. 75 m) were supplied by Polymicro Technologies (Pheonix, AZ). 
Metal capillaries (O.D. 400 m, I.D. 200 m and O.D. 318 m, I.D. 158.75 m) were purchased 
from Small Parts, Inc. (Miramar, FL). PTFE tubings (O.D. 1/16″, I.D. 400 m and O.D. 1/16″, 
I.D. 205 m) were supplied by McMaster Plastics (Scarborough, ON). Standard 1/16″ fittings 
were purchased from Upchurch (Oak Harbor, WA). Ultrapure water was generated in-house on a 
Millipore Milli-Q Advantage A10 system. The rotary grinder (Craftsman Co. Hoffman Estates, 
IL) was used to sharpen the metal capillary.  
 
3.2.2 Microfluidic Device Fabrication. The multistep microreactor is an integration of a rapid 
mixing module [31] and a rapid proteolysis module [32] that were developed earlier.  The device 
was fabricated on blank poly(methyl methacrylate) or PMMA substrate which  was  purchased 
from Professional Plastics (Fullerton, CA) in rectangular  block with dimension of  8.9 cm x 3.8 
cm x 0.3 cm. The microfluidic channels and well (32 mm x 5 mm x 0.01 mm) were etched on 
PMMA using a LASER engraver (Universal Laser, Scottsdale,AZ) following the protocol 
described by Rob et al. [31]. The concentric capillary mixer was incorporated in the central 
channel of the device using a soldering iron. Two additional metal capillaries were similarly 
incorporated into adjacent channels to support connections to infusion pumps (Harvard, 
Holliston, MA) using standard Upchurch fittings. A closed polyimide-coated glass capillary was 
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used as a static mixer to ensure efficient mixing of acid and deuterated protein before the 
quenched solution was transferred to proteolytic module. Pepsin was covalently attached to the 
floor and ceiling of the reactor well using  protocol described by  Brown et al. [33]  Parafilm 
was used as gasket to obtain liquid-tight seal between the two activated PMMA blocks.  A 
custom built clamp was obtained from LAC Machine & Tooling Limited, ON to pressure-seal 
the microfluidic device [32]. 
 
3.2.3 DAHP synthase (Phe) purification. Escherichia coli Phe-regulated DAHP synthase 
(aroG) was produced in E.coli BL21*(DE3) cells harboring a pET300/aroG plasmid which 
contained aroG with an N-terminal TEV-protease-cleavable His6-tag. Transformed BL21*(DE3) 
E. coli cells were grown at 37 °C in 1 L of LB broth with 100 µg/mL of ampicillin to OD600 = 
0.6. DAHP synthase expression was induced with 0.3 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 37 °C for 4 h.  Cells were harvested by centrifugation at 8000 
 g for 20 min, resuspended in 15 mL of buffer A (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 
50 mM imidazole, 1 mM phenylmethylsulfonyl fluoride).  All subsequent steps were carried out 
at 4 °C.  Cells were lysed by passage through EmulsiFlex-C5 High Pressure Homogenizer at 
10,000 psi.  Cell debris was removed by centrifugation for 30 min at 10,000 × g.  DAHP 
synthase was purified by nickel affinity chromatography on a Ni++-charged 1 mL HiTrap 
chelating Sepharose (GE Healthcare) column.  DAHP synthase was eluted with buffer B (50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 500 mM imidazole).  No other bands were visible by 
SDS/PAGE electrophoresis. The N-terminal His6-tag was removed by treating purified DAHP 
synthase overnight at 4 °C with His6-tagged TEV protease (plasmid provided by Dr. Murray 
Junop, McMaster University) in 1:4 (TEV:DAHPS) molar ratio, along with 1 mM EDTA, 1 mM 
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dithiothreitol and 10% (v/v) glycerol.   The reaction mixture was buffer exchanged into 20 mM 
Tris-HCl, pH 7.5 and run through a Ni++-charged chelating Sepharose column, as above, to 
remove the cleaved N-terminal tag, uncleaved Hig6-tagged DAHP synthase and His6-tagged 
TEV protease.  Pure DAHP synthase was dialyzed into 10 mM ammonium acetate, pH 7.6. 
 
3.2.4 H/D Exchange Measurements. HDX studies were carried out with ubiquitin, cytochrome 
c and DAHP synthase using the integrated microfluidic chip as a custom electrospray ionization 
(ESI) source (Figure 3.1). The chip was directly interfaced with a modified QSTAR® Elite 
hybrid quadrupole time-of-flight (QqTOF) mass spectrometer (Sciex, MDS Analytical 
Technologies, Concord, ON).  50 M ubiquitin, 500 M cytochrome c and 270 M DAHP 
synthase were mixed with D2O (1:3) in the rapid mixing module of the device (pD 7.6). The 
position of the mixer in the mixing module was adjusted manually to control the labeling time.  
 
Using flow rates of  1L/min for protein solution and 3 L/min for  D2O we were able to 
achieve labeling times  from 42 ms to 10 sec. Labeling was rapidly quenched  by dropping the 
solution to pH 2.6 by using a 4% acetic acid solution (pH 2.3) at 9 L/min (2 x 4.5 L/min). 
Digestion and electrospray was therefore ultimately carried out in a 77:23 H2O/D2O mixture. 
Digestion of deuterated proteins and transfer to the ESI emitter was carried out in approximately 
7 s to minimize the back-exchange of backbone amides (protons on side chain and termini were 
assumed to be fully equilibrated with the electrosprayed solution prior to ionization). Peptide 
exchange levels were modeled using a custom built FORTRAN program, based on an analytical 
framework described previously [19], with ‘offset’ adjustments for backbone amide back- 
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Figure 3.1. The microfluidic device. (a) A schematic depiction. Solutions are injected at the 
‘near’ side of the device and ESI is carried out at the ‘far’ end. HDX is conducted under ‘native’ 
conditions (pD 7.6) in the first phase with adjustable labeling times from ~ 40 ms to 8 s. This is 
followed by HDX quenching, which is achieved by dropping the pH to 2.5. The labeled protein 
is then injected into the proteolytic reactor, generating labeled peptides which can be located on 
the native structure. (b) A photograph of the device, with coin for scale. 
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3.2.5 Data Analysis Method. Under native conditions, the hydrogen bonding and/or solvent 
accessibility characteristics of most backbone amides are such that the ‘closing’ rate for a given 
amide kcl is usually much greater than the intrinsic rate at which HDX would occur with a 
completely ‘open’ configuration kint. In this regime, called the EX2 limit, the observed rate of 
exchange kex kex is a function of the ‘opening’ rate kop, kint and kcl in the following relationship. 
         (3.1) 
The intrinsic rate is dependent on primary sequence and, thanks to a substantial effort by 
Bai and co-workers [34], intrinsic rates for any sequence can be calculated to within a good 
approximation based on experimental parameters [35]. Thus, for any particular backbone-amide, 
it is possible to determine the ‘open’/‘closed’ equilibrium represented by Kop simply by dividing 
out kint. This value (kex/kint) can be interpreted as a quantitative measure of the local 
thermodynamic stability of secondary structural elements [36], but is more often inverted and 
described in more qualitative terms as a protection factor (PF) [37]. 
 
 While it is relatively easy to interpret the physical meaning of a single backbone amide 
proton’s PF value, the acquisition of ‘segment averaged’ HDX data presents a problem in that 
the observed increase in deuteration per unit time D(t) is a function of multiple kex 
 
    (3.2) 
where m is the number of backbone amides in the segment,   is the ‘open’/‘closed’ 
equilibrium constant at residue i and  is the intrinsic rate constant for residue i. The 
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bracketed terms in the exponent could be combined into kex, but here they are kept separate for 
discussion below. In conventional experiments where there is a lengthy LC step, the index would 
start at i = 3 due to rapid back-exchange at the i = 2 position and ‘instantaneous’ equilibration of 
exchange at the i = 1 position during enzymatic hydrolysis of the peptide bond. In our setup, 
however, post-quench residence times are sufficiently small that back-exchange at the i = 2 
amide is predicted to  10% in all cases. We therefore start our index at i = 2. 
 
 The challenge in analyzing ‘segment averaged’ data is that, since Kop may be different for 
each amide, the system is underdetermined and cannot be analyzed quantitatively. However, a 
semi-quantitative approach can provide reliable ‘average’ protection factors in many cases. 
There is some debate about the best expression to use when fitting ‘segment averaged’ D(t) 
profiles. The ‘ideal’ multiexponential with m-1 terms shown in Equation 3.2 would have too 
many variable parameters to provide meaningful individual rates for segments with more than 
two ‘exchange active’ amides. Thus, ‘segment averaged’ data are usually fitted using an 
unmodified single or double-exponential expression [22]. In the event that the kex within the 
peptide are not widely dispersed, a single exponential fit will provide a good approximation of 
the average kex. If there are two distinct populations of kex values within the peptide (e.g., if the 
peptide includes both a structured region and a loop), and the values within each population are 
not widely dispersed, then a double exponential fit will provide a good estimate of the average 
kex within each population.  
 
 Since our measurements are conducted after only a maximum of a few seconds of D2O 
exposure, the observed HDX kinetics are dominated by backbone amides with Kop in the range 
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of approximately 0.01 to 1, which occurs in weakly structured regions. In structured regions, Kop 
values typically range from 1  10-3 to 1  10-5. Exchange at these slow exchanging amides is in 
a pre-equilibrium steady-state on the time-scale of our measurements, thus their (usually very 
minor) contribution to the observed kinetics can be approximated as linear. We therefore use the 
following expression to fit our D(t) profiles 
       (3.3) 
where Nfast is the number of amides that undergo significant exchange on the time-scale of our 
experiments, kex is the average observed exchange rate for the ‘fast’ exchangers, Nslow is the 
number of amides involved in the slow exchange process and kslow is the average HDX rate for 
‘slow’ exchangers. Note that, although Nslow and kslow are separable (by subtracting Nfast from the 
total number of amides in the peptide), we cannot obtain good estimates of kslow from data taken 
on this timescale. We include the term only to achieve a more accurate determination of kex.  
  
In order to simplify comparisons for the reader, we report D(t) in units of ‘% exchanged’ 
which normalizes the data to the number of exchangeable backbone amides (m - 1) and accounts 
for the labeling offsets caused by the labeling solution (in our experiments, exchange was 
conducted in 80% D2O) , back-exchange and equilibrated exchange at side-chains and termini 
(our electrosprayed solution contains 23% D2O, thus exchangeable side-chains and termini will 
be 23% labeled from t = 0). We were able to achieve good fits to all of our data using Equation 
3.3, in spite of the fact that it assumes a wide separation between kex and kslow which may not 
occur in all peptides. Most importantly, fits to Equation 3.3 should provide the most accurate 
estimate of kex (the term corresponding to conformational flexibility in dynamic regions) from 
our short labeling-time HDX measurements. 
83 
 
 With amides in secondary structures not contributing significantly to the observed 
exchange, it is often possible to attribute D(t) specifically to loop amides by comparing Nfast to 
the predicted number of loop amides Nloop from an X-ray or NMR structure. For example, if a 
peptide is 70% helix and 30% loop in the appropriate structure, then Nfast should be roughly 
30%. This is a rough estimate because it is often difficult to define precisely the starting point of 
a secondary structure in terms of hydrogen bonding, for example at the N-termini of -helices 
(where the ‘initial’ 4 amides may or may not be hydrogen bonded). Another assumption is that 
the available X-ray or NMR structure reflects exactly what is present in solution, which is not 
always the case. With cytochrome c, for example, we found generally good agreement between 
Nfast and Nloop, with a few exceptions (corresponding to ‘rigid’ loops) where Nfast was 
significantly lower. In the case of DAHP, however, the available structure corresponds to the 
substrate-bound form of the enzyme while we were monitoring the free protein. As it turns out, 
these structures are substantially different, resulting in essentially no correlation between Nfast 
and Nloop predicted from the available structure (with a few important exceptions at the tetramer 
interface, see discussion).  
 
 Where there is good agreement between Nfast and Nloop, we can construct a ‘loop amide 
only’ intrinsic rate multiexponential, D(t)int, which we use to generate ‘segment averaged’ PFs 
specifically reflecting loop dynamics. In the event that Nfast is substantially smaller than the 
expected number of loop amides, we can provide a PF estimate based on the average intrinsic 
rate for all loop amides (even though only a subset are undergoing exchange on our time-scale) 
and a lower and upper bound, determined by taking the average of the Nfast number of lowest and 
highest intrinsic rates, respectively. Values of Nfast that are substantially higher than Nloop suggest 
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that the X-ray or NMR structure being used to define the loop does not reflect the sample in 
solution. In this case, we can make no assumptions about which amides are contributing to the 
observed exchange, and the PF is calculated using the average of all intrinsic rates from the 
segment.  
 
Therefore our time-resolved HDX data differ from those collected in conventional 
experiments in that the time-scale is sufficiently short that we expect essentially no contribution 
from amides in secondary structures. In cases where we can define the position of loop amides 
based on a reported X-ray or NMR structure, we compare the amplitude of the observed 
exchange Nfast to the number of loop backbone amides Nloop. If Nfast and Nloop are in reasonable 
agreement in a given segment, then it is likely that the reported structure reflects the solution 
conformation under our conditions, and we attribute the observed exchange specifically to loop 
amides. The condition Nfast << Nloop suggests that the loop reported in the structure is extensively 
hydrogen bonded and may include unreported secondary structure. Conversely, when Nfast >> 
Nloop, this would indicate that a reported secondary structure element is weakly populated (or 
possibly not even present) under our conditions. The observed HDX kinetics profiles are fit to a 
modified single exponential expression as described earlier. From this fit, we extract the segment 
averaged rate of exchange kex. Protection factors (PFs) are defined as kint/kex where kint is the 
average intrinsic rate of exchange for the segment. If Nfast  Nloop, the average intrinsic rate kint is 
calculated specifically from loop amides. 
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3.3 RESULTS AND DISCUSSIONS 
 
3.3.1 Microfluidics. The integrated microfluidic device for time-resolved HDX experiments is 
shown in Figure 3.1. PMMA was selected as the substrate to allow straightforward fabrication 
via laser ablation [31], however, this introduced a risk of sample contamination due to 
dissolution of PMMA, particularly in the acid quench solution channel. Fortunately, blank 
control experiments showed no signs of PMMA degradation, which we have observed 
previously as the appearance of a polydisperse PMMA polymer signal in the range of 300- 1500 
m/z . In earlier iterations of our proteolytic reactor, we used pepsin-agarose beads which were 
attached to the floor of the reactor well via adhesion [32, 38]. The activity of these reactors was 
sufficient, but the continuous-use lifetime was limited to ca. 8 h. In this study, we used a 
covalent attachment protocol developed by Brown and co-workers [33, 39] which decreased 
digestion efficiency slightly, but improved the continuous-use lifetime to more than 56 h. 
 
 To facilitate HDX experiments, our primary design objective was to maintain efficient 
protein digestion while minimizing back exchange which, in practice, meant optimizing the 
geometry of the proteolytic reactor well. We found ultimately that a well with dimensions length 
= 32 mm, width = 5 mm and depth = 10 m (vol. = 1.6 L) provided sufficient digestion while 
keeping back-exchange sufficiently low as to have a negligible impact on the data [40]. While 
always below 5%, back exchange was highly variable run-to-run, suggesting that it may have 
been arisen from ESI source conditions (back-exchange was monitored using a peptide with 
known exchange characteristics, bradykinin, as an internal standard) [40].  At the flow rates 
used, the reactor well and transfer volumes corresponds to a total post-quench residence time of 
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approximately 8 s prior to ESI. An analysis of the dependence of sequence coverage and peptide 
length on geometry is provided in Table 3.1. Using the geometry given above, and activating 
both on the ‘floor’ and  the ‘ceiling’ of the reactor, sequence coverage was 85% for ubiquitin, 
60% for cytochrome c and 60% for DAHP synthase with an average peptide length of 5 a.a. 
(ubiquitin), 9 a.a. (cytochrome c) and 6 a.a. (DAHP synthase). These statistics translate into 
sufficient spatial resolution to provide meaningful measurements of local conformational 
dynamics, but as always in bottom up experiments, enhancement of digestion efficiency (without 
increasing residence times) is an avenue for further development. 
Table 3.1: Effect of well design on sequence coverage and average peptide length in 
cytochrome c. 
Well geometry Well dimension 
( mm x mm x mm) 
Well volume 
(μL) 
Sequence 
coverage (%) 
Average 
Peptide length 
Square 2 x 2 x 0.01 0.04 50 25 
Square 3 x 3 x 0.01 0.09 53 23 
Square 4 x 4 x 0.01 0.16 55 20 
Rectangle 8 x 2 x 0.01 0.16 55 18 
Rectangle 16 x 5 x 0.01 0.8 60 16 
Rectangle 32 x 5 x 0.01 1.6 60 14 
Rectangle 32 x 20 x 0.01 6.4 62 12* 
Rectangle 32 x 5 x 0.01** 1.6 60 9 
 
* This geometry provided the best sequence coverage, but the additional dead-time resulted in 
substantially more back exchange (approximately 20%) 
** This well design, which was ultimately selected, was activated both on the ‘floor’ and 
‘ceiling’.  
  
The adjustable capillary mixing component, which is adapted from a mixer introduced by 
Wilson and Konermann [41] allowed HDX labeling times between roughly 40 ms and 8 s. We 
used the mixer in static mode, meaning that the mixer is held at a fixed position to allow for 
indefinite time acquisitions at a single reaction time-point. This was mainly to allow for 
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complete flushing of old material from the proteolytic reactor prior to the initiation of 
measurements at a new time increment. We found that flushing for 5 minutes after adjusting the 
capillary position to the new time-point was sufficient to prevent carryover of old material, based 
on stabilization of the exchange level for all peptides. 
 
3.3.2 Single Time-point Structural Measurements. One of the most straightforward 
applications of spatially resolved HDX measurements is a crude (but high throughput) structural 
analysis based on a single time-point measurement [5, 42]. These experiments rely on the 
substantial difference between Kop in structured and unstructured regions to determine the 
locations of secondary structures. The approach is feasible because kint is distributed over a much 
narrower range (around 2 orders of magnitude) than Kop; thus amides with high intrinsic rates in 
structured regions will still exchange much more slowly than amides with low intrinsic rates in 
unstructured regions. A single time-point spatially-resolved HDX profile should therefore reflect 
the locations of secondary structure elements (and to a lesser extent, solvent accessibility) [22]. 
As labeling time increases, however, amides with progressively lower Kop begin to acquire a 
significant amount of label and the ‘secondary structure map’ begins to blur. Thus, the optimal 
labeling time is one that is sufficiently long to minimize contributions from the segment 
averaged kint and sufficiently short to maximize the contrast between structured and unstructured 
regions. At physiological pH, this would correspond to a sub-second labeling time on the order 
of 100 ms. 
 
 To demonstrate the acquisition of a secondary structure map using our apparatus, we 
have acquired a single time-point (100 ms) HDX profile for ubiquitin (Figure 3.2). In general, 
the profile agrees with the known structure of ubiquitin, with -helices and -strands exhibiting 
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a substantially lower deuterium uptake than loops. One interesting feature is that even the most 
highly labeled loops underwent only 50% of their potential deuterium uptake, whereas, based on 
kint alone, most should be essentially 100% labeled. This would suggest that amides located in 
loops still have substantial attenuation of kint by Kop, a finding that is corroborated by NMR 
CLEANEX measurements which typically show loop Kop values between 1 and 0.1 [30]. There 
was also low-level labeling (up to 20%) in regions of secondary structure. This can be attributed 
somewhat to averaging of exchange levels in overlapping segments, but mostly it results from 
the fact that not all amides in secondary structure elements are hydrogen bonded (e.g. the N-
termini of -helices and the outward-facing side of edge -strands). 
 
 
 
 
 
 
 
 
 
Figure 3.2. A crude secondary structure analysis of Ubiquitin using a single, sub-second HDX 
time-point (100 ms). The y-axis corresponds to deuterium uptake in ‘% deuterated’ while the x-
axis represents the primary sequence from the N-terminus on the left. Exchange levels of 
overlapping peptides are averaged, and the small ‘uncovered’ regions are assumed to be an 
average of the two flanking exchange levels.  
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 There are some regions where the profile is not as expected, most notably the large loop 
preceding the C-terminal -strand (the 4 - 5 loop) where low HDX uptake suggests 
substantially more protection than would be expected in a loop. In fact, this observation is 
supported by NMR-based measurements including extended timescale order parameters which 
indicate a relatively low degree of conformational flexibility in this loop on the s timescale 
[43]. NMR HDX measurements also show an intermediate degree of protection (i.e. substantially 
more than a typical loop, but less than a secondary structure) in this region [44]. The X-ray 
structure (PDB code 1UBQ) [45] suggests that this increased protection may stem from 
extensive hydrogen bonding of 4 - 5 loop amides with residues in the N-terminus of 1-helix 
and the 5-strand. 
 Taken together, our ubiquitin data illustrate both the advantages and disadvantages of 
using ms timescale deuterium pulses for secondary structure profiles. The contrast between 
secondary structures and loops (where they are detected) is very high, but the short labeling time 
results in an over-sensitivity to intermediate degrees of protection (e.g., in the 4 - 5 loop) 
which can lead to ‘false positives’ for secondary structure. On the other hand, these single time-
point ‘false positives’ hint at the primary advantage of short labeling time HDX kinetics, namely 
the ability to distinguish very low protection from low - moderate protection in weakly 
structured regions. 
 
3.3.3 Characterizing Conformational Dynamics in Weakly Structured Regions. We used 
loop dynamics in native cytochrome c to illustrate the ability to characterize dynamics in weakly 
structured regions at physiological pH. Cytochrome c is not an ideal candidate for our approach 
in that it is a poor substrate for pepsin [46], however, its native state conformational dynamics 
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have been extensively characterized, providing the best option for a methodological comparison 
[47, 48]. Sequence coverage was 60% overall, with 100% coverage in the C-terminal half of the 
protein but no peptides detected from the N-terminal region. Some of this lack of coverage at the 
N-terminus may stem from the presence of covalently bound heme (Cys 14 and Cys 17), which 
would likely have had a deleterious effect on pepsin activity. 
 
 To accurately characterize conformational dynamics, it is necessary to monitor deuterium 
uptake as a function of time, i.e., HDX kinetics. Typical raw data that contribute to the kinetic 
profiles for 3 peptides are shown in Figure 3.3 .The ‘% exchanged’ value for each time-point is 
determined by fitting the observed isotopic distribution to a theoretical one generated using a 
custom FORTRAN program (black circles) with adjustment to account for various labeling 
offsets caused by the composition of the exchange solution and equilibrated HDX on side-chains 
and termini (see data analysis section). We observe a continuous mass increase as a function of 
time indicating that exchange is in the EX2 regime, which is typical under native conditions.  
 
 To analyze the HDX kinetics, we plot ‘% exchanged’ vs. time (Figure 3.4), which 
corresponds to D(t) as discussed in the data analysis section. HDX kinetics plots for 9 
representative cytochrome c peptides together with the ‘loop localized’ intrinsic rate profiles 
D(t)int. The observed profiles are colored by PF from blue (high protection) to red (very low 
protection). A graphical summary of the cytochrome c results (Figure 3.5) shows the observed 
peptides mapped onto the solution structure of horse heart cytochrome c (PDB code 1AKK) [49] 
and colored according to the PF from blue (high protection) to red (very low protection). These 
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PFs are derived exclusively from short labeling pulse HDX measurements, corresponding to 
exchange processes that are essentially complete after 4.5 s.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Raw data for HDX kinetics in three representative cytochrome c peptides. The ‘% 
exchanged’ values were determined by fitting the observed isotopic distribution to a theoretical 
one (black circles) generated from a FORTRAN program developed in-house. Adjustments were 
made to account for equilibrated exchange on side chains and termini due to the composition of 
the final electrosprayed solution. 
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Figure 3.4. Representative kinetic plots of ‘% exchanged’ vs. time for 9 peptides from 
cytochrome c. The ‘loop amide only’ profiles based on the intrinsic rates D(t)int are shown in 
black. The dashed line represents 100% exchange of loop amides (i.e. Nloop). The measured 
profiles are colored by PF; blue (strong protection), green (moderate protection), orange (weak 
protection), red (very low protection). For segment 23 - 38, marked with (*), Nfast (27%  5) is 
not comparable to Nloop (100%). The intrinsic profile for that segment was therefore constructed 
from the lowest 5 (i.e. 30% of 15 amides) intrinsic rates, which gives the ‘lower bound’ PF of 
16. Error bars are from two or three replicates depending on the number of experiments in which 
the peptide was detected. 
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Figure 3.5. A graphical representation of cytochrome c loop dynamics based on time-resolved 
HDX data. Differing levels of protection in loops are mapped onto the solution structure for 
oxidized horse heart cytochrome c (1AKK) [49] by PF: blue (strong protection), green (moderate 
protection), orange (weak protection), red (very low protection). Structured regions covered by 
observed peptides are shown in light grey. Regions for which no peptides were observed are 
colored dark grey. Image generated using Protein Workshop [50]. 
 
On this timescale, there should be virtually no contribution from regions with secondary 
structure, an assumption that can be tested by comparing the amplitude of the observed exchange 
to the amount of secondary structure in the peptide. For example, the peptide corresponding to 
residues 84 - 95 is 30% loop in the native structure. The amplitude for the ‘fast’ exchange 
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component Nfast is 32  8%, which is agrees very closely with the expected contribution from 
loop amides. We observe a similar correlation for almost all peptides, which indicates a good 
agreement between the NMR structure and the actual structure of the protein in solution and 
supports the assumption that the observed exchange is attributable specifically to loop amides.  
 
Coloring is therefore restricted to loops (Figure 3.5) and average kint values for PF 
calculations are derived from loop amides only. In the instance where Nfast is substantially lower 
than the number of loop amides (i.e. segment 22 - 37), the whole peptide is shown colored and 
the PF was estimated using the average kint for the whole segment. Nloop and Nfast values for each 
peptide are provided in Table 3.2, together with ‘loop localized, segment averaged’ PFs. 
 
Table 3.2: Time-resolved HDX parameters for peptides from cytochrome c. 
Segment Nloop (% of peptide) Nfast ( % of peptide)‡ PF 
23-38 100 27  5 57  12* 
38-65 38 41  6 12  3 
58-66 37 31  4 5  1 
68-81 44 40  6 10  3 
82-97 33 25  6 6  3 
84-97 23 26  7 8  4 
84-95 30 32  8 12  5 
96-105 33 27  6 22  6 
98-105 40 32  4 25  5 
99-105 47 36  8 27  8 
 
 
‡ Error measurements are based on two or three replicates depending on the number of 
experiments in which the peptide was detected. 
*Since Nfast << Nloop for this peptide, we can provide only an estimate of the PF based on the 
average intrinsic rate for the whole peptide. We can also determine upper and lower bounds by 
assuming that the amides contributing to the observed exchange are those with the lowest and 
highest intrinsic rates, respectively. 
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From the HDX kinetics measurements overall, it is clear that the loops in cytochrome c 
have substantially different dynamic properties, with ‘segment averaged’ PFs ranging from 5  1 
(2 - 3 loop) to 57  12 (the 1 - 2 loop). While there are to the best of our knowledge no 
directly comparable measurements of native cytochrome c loop dynamics under native 
conditions, our profile is generally in good agreement with ‘native state HDX’ thermodynamic 
stability measurements by Englander and co-workers [47, 48] and can be rationalized by 
focusing on the influence of the heme prosthetic group. For instance, the least dynamic loop 
segment  (22 - 37)  is from the same loop as the heme covalent attachment site (Cys 14 and Cys 
17)  and is likely rigidly held in place by interactions between heme and its binding pocket. This 
loop is identified in native HDX experiments as being particularly resistant to denaturation [47, 
51] . In fact, many backbone amides in the 22 - 37 segment are so strongly hydrogen bonded that 
exchange is only at 40% after 48 h of incubation in D2O (data not shown). Since on our rapid 
time-scale measurements detected exchange in only 5 of the amides from this 15 residue peptide 
(Nfast = 27  5%, Nloop = 100%), the upper and lower bounds on the PF are widely separated. 
Taking the slowest 5 intrinsic rates, the PF would be 16, corresponding to the second-highest 
protection factor bin (green). If we assume that amides contributing to the observed exchange are 
those with the 5 fastest kint, the PF is 102, corresponding to the highest protection factor bin 
(blue). In either case, in appears all amides in the 1 - 2 loop are substantially protected. 
  
The most rapid exchange was measured in the 2 - 3 loop (PF = 5  1) which has only 
one significant contact with heme (a hydrogen bond between a heme carboxylate and the Trp59 
1N proton). The 4 - 5 loop showed a dual dynamic character, with significant protection near 
the 4 helix where there are substantial contacts with heme (including Met80 which is an axial 
96 
 
ligand for the heme iron), and lower protection as the loop moves away from the heme binding 
pocket approaching the 5 helix. At pD 7.6, all of the exchange processes that allow us to 
compare loop dynamics are complete within a few seconds of initiating exchange. The time-
resolution afforded by our apparatus is therefore crucial to the acquisition of loop dynamics 
profiles of this type. 
 
3.3.4 Localizing Dynamics in a Large Tetrameric Enzyme. The primary advantage of bottom-
up HDX is that it is a general method. It is applicable to virtually any protein and is not size-
limited. Here we demonstrate a time-resolved, bottom-up HDX analysis on the enzyme DAHP 
synthase, a 154 kDa homotetramer. Our interest in DAHP synthase stems from ‘global’ HDX 
measurements (i.e., no digestion prior to analysis) in which it was observed that, in the absence 
of substrate, the protein underwent a very large (~65%) burst-phase of backbone amide exchange 
within 20 s of D2O exposure, suggesting an unusually high degree of conformational flexibility 
in the unbound tetramer. The substrate-bound protein, on the other hand, showed a more typical 
~25% burst-phase (data not shown). This was consistent with efforts to crystallize the protein, 
which were successful only in the presence of substrates (or competitive inhibitors).[52] In this 
section, we use our microfluidic device to localize and characterize this burst-phase exchange. 
  
Typical kinetic profiles from three DAHP peptides (Figure 3.6) illustrate the major 
difference between DAHP exchange kinetics and those from cytochrome c, which was that the 
majority of DAHP peptides showed no correlation between Nfast and Nloop values. Nloop was 
determined from the available substrate-bound structure (PDB code 1KFL) [52].  For example, 
the peptide 118 - 124 is 100% -helix in the 1KFL structure and yet we still detect a large 
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number of backbone amides undergoing exchange (Nfast = 77  15%) with low protection. This 
would suggest that the 118 - 124 -helix is at most weakly structured in the absence of substrate. 
The general lack of correlation between Nfast and Nloop in our DAHP data indicates substantial 
structural and/or dynamic differences between the substrate-bound and unbound forms of the 
protein (which is expected based on the ‘global’ HDX results). Nonetheless, electrospray mass 
spectra of DAHP strongly suggested that the protein was able to retain its native tetrameric 
configuration in the absence of substrate (data not shown). In fact, the HDX data are consistent 
with this observation in that those peptides that do show a good correlation between Nfast and 
Nloop are concentrated at the tetramer interface (Figure 3.6). Thus, we can infer that the tetramer 
interface structure reported in 1KFL is largely intact in the unbound protein. 
 
 
 
 
 
 
 
 
Figure 3.6. HDX kinetics for representative peptides from DAHP synthase. Intrinsic rate 
profiles D(t)int  for each segment are shown in black. The measured profiles are represented by 
filled circles colored according to the extracted PF: blue (strong protection), green (moderate 
protection), red (low protection). For most peptides, there is little correlation between Nfast and 
the number of loop amides in the substrate-bound structure.  
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 A second general difference from the cytochrome c data is that the overall level of 
exchange is much higher, averaging 73% (average exchange level for cytochrome c = 30%). 
This is consistent with a weak hydrogen bonding network undergoing ‘molten globule-like’ 
dynamics over a significant fraction of the protein [53]. Characterizing this weak network is 
important, since it may represent a template for the rapid development of structure upon 
substrate binding. ‘Segment averaged’ PFs, Nfast amplitudes and Nloop for each DAHP  peptide 
are provided in Table 3.3.  
Table 3.3: Time-resolved HDX statistics for peptides from DAHP synthase. 
Segment Nloop (% of peptide) Nfast (% of peptide)‡ PF 
3-9 100 57  10 16  6 
18-23 50 59  12* 5  4 
24-36 17 100  5 27  6 
47-55 75 55  10 6  3 
69-72 0 48  11 5  3 
83-88 100 97  9* 2  1 
88-91 0 69  12 2  1 
96-108 77 100  11 11  3 
97-102 80 100  17 10  4 
105-113 25 61  8 6  2 
108-114 50 92  10 5  3 
108-117 67 74  12* 15  5 
118-123 0 73  10 9  3 
118-124 0 77  15 8  4 
134-140 33 98  19 23  9 
158-165 57 73  11 15  5 
186-191 100 68  14 24  8 
196-203 0 76  16 11  6 
198-206 38 45  9* 12  3 
205-216 55 64  10* 14  4 
216-220 50 54  7* 24  5 
222-226 50 50  6* 32  5 
232-235 33 98  16 4  1 
250-253 0 75  18 7  3 
254-257 33 73  16 9  4 
258-262 75 73  12* 5  2  
262-267 40 55  10 3  1 
262-268 50 68  10 5  2 
276-281 0 18  5 25  11 
282-293 18 74  13 20  6 
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284-293 22 62  9 12  3 
289-294 60 59  8* 12  2 
290-296 83 87  17* 16  4 
292-296 100 72  15 11  3 
300-305 100 74  11 8  2 
308-315 100 47  18 23  11 
309-313 100 60  15 32  8 
343-346 0 50  12 19  9 
 
‡ Error measurements are based on two or three replicates depending on the number of 
experiments in which the peptide was detected. 
* Indicates peptides where there is a reasonable correlation ( 10% difference) between Nloop and 
Nfast. PFs for these peptides were generated using ‘loop localized’ intrinsic rate profiles. The 
positions of these peptides in the substrate-bound structure (1KFL) are shown in Figure 3.7a. 
 
 
 
 
 
 
 
 
Figure 3.7. DAHP exchange profiles mapped on to the substrate-bound 1KFL structure. (a) 
Highlighted regions correspond to peptides in which Nfast is in reasonable agreement with Nloop, 
suggesting similarity between the apo-protein structure and the PEP-bound structure 
(1KFL).[52] Many of the peptides with this property are located at the tetramer interface. (b) 
Observed peptides are mapped onto the PEP-bound DAHP structure (1KFL), colored by PF: 
blue (strong protection), green (moderate protection), red (low protection). Note that on our 
relative scale even ‘strong protection’ corresponds to loop-like exchange (PF   32), thus many 
regions that are structured in the substrate-bound state (Nloop = 0) are clearly much less so in the 
apo-protein (Nfast >> Nloop). Images were created using Protein Workshop [50]. 
ba
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The DAHP synthase dynamics profile is mapped onto the substrate-bound structure 
1KFL (Figure 3.7b) with observed peptides colored by PF from blue (high protection) to red 
(very low protection). Based on the profile, it is evident that the large burst-phase of exchange is 
localized to an area surrounding the active site, where all peptides underwent substantial 
exchange independent of their structural content in 1KFL. All of these segments are well 
positioned to be strongly influenced by the presence of substrate in the active site.  Least 
protected was the region corresponding to the 3-helix (PF = 7  3). Two helices located at the 
center of the group of -helices surrounding the active site (11 and 10) had a significant level 
of protection (PF 27  8 and 20  6) in the unbound protein, suggesting the presence of 
‘residual’ structure. These regions and others with significant ‘residual’ structure in the 
unbound-protein (blue color, Figure 3.7b) may represent nuclei for the rapid development of 
structure upon substrate binding. 
 
 
3.4 CONCLUSIONS 
  
We have demonstrated a new, broadly applicable approach for measuring dynamics in 
weakly structured regions of proteins. The method represents a powerful tool for characterizing 
dynamics in loops, molten-globules and other weakly structured elements that are inaccessible in 
conventional experiments at physiological pH. By incorporating the entire HDX experimental 
workflow onto a single microfluidic chip, and using short (ms to s) labeling times, we were able 
to: (i) produce high contrast secondary structure predictions using single time-point 
measurements, (ii) differentiate the dynamic properties of loops and (iii) characterize weak 
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hydrogen bonding networks in ‘molten globule-like’ protein segments. These experiments are 
straightforward, inexpensive and have a wide range of applications in ligand binding, protein 
aggregation/amyloidosis. The method provides a versatile platform to enhance our understanding 
of dynamics in weakly structured regions and may offer much-needed insights into the structural 
properties of ‘intrinsically disordered’ proteins. 
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CHAPTER 4 
The Effect of Ligand Binding on Conformational Dynamics of DAHP 
Synthase using Microfluidics Enabled Hydrogen/ Deuterium Exchange 
 
4.1 INTRODUCTION  
The enzyme 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP synthase) is the first 
enzyme of the shikimate pathway, associated with the biosynthesis of the aromatic amino acids 
in microorganisms and plants [1]. Shikimate pathway involves a sequence of seven metabolic 
steps where in the first step DAHP synthase catalyzes the stereospecific aldol condensation of 
phosphoenolpyruvate (PEP) and D-erythrose 4-phosphate (E4P) to DAHP and inorganic 
phosphate (Figure 4.1).  
Phosphoenolpyruvate (PEP) + D-erythrose 4-phosphate (E4P) + H2O  3-deoxy-D-arabino-
hept-2-ulosonate 7-phosphate (DAHP) + phosphate (Pi) 
 
  In following sequential steps, DAHP undergoes several other transformations before it is 
converted into chorismate, the precursor of the aromatic amino acids phenylalanine 
(Phe), tyrosine (Tyr), and tryptophan (Trp) and many aromatic secondary metabolites [2-4]. 
Furthermore, DAHP synthase regulates the amount of carbon entering the shikimate pathway 
which involves the enzyme inhibition by the three major end products of the biosynthetic 
pathway i.e. Phe, Tyr, Trp. The concentrations of each of the three aromatic amino acids are 
continuously monitored in the cell. When there is too much of any one of them, that one will 
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allosterically control the DAHP synthase by “turning it off”. This regulation can be 
accomplished primarily through two different mechanisms: Feedback inhibition and 
transcriptional control.  The most comprehensively investigated DAHP synthase has been the 
Escherichia coli enzyme system. In E. coli, DAHP synthase is found as three isoenzymes where 
the organism encodes each of them by the structural genes: aro F (Tyr-sensitive DAHP 
synthase), aro G (Phe-sensitive DAHP synthase), aro H (Trp-sensitive DAHP synthase) [5, 6] . 
In the current work, we focused on studying conformational dynamics of Phe-sensitive DAHP 
synthase upon ligand binding. 
  
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Simplified description of two possible pathways for biosynthesis of  DAHP in 
DAHP synthase [7].  
109 
 
The biosynthetic pathway of aromatic amino acids is absent in animals, hence the 
products of this pathway represent essential amino acids that must be obtained for the animal's 
diet.  Therefore it is important to understand the enzyme mechanism in order to design synthesis 
of aromatic amino acids that underlies critical in the diets of mammals. Additionally, DAHP 
synthase responses to a broad range of developmental cues and environmental stimuli 
mechanisms which controls carbon flow into the shikimate pathway [7, 8]. This alters the 
demand for aromatic amino acid-derived metabolites in plants during plant development and/or 
during periods of environmental stress such as wounding or pathogen attack. Under stress 
conditions, plants produce high amount of lignin which is directly mediated by aromatic 
compound synthesis [9].  In many farming industries, controlling the bacterial growth is 
extremely challenging.  An accepted inhibitor for DAHP synthase would inhibit pathogen attack 
while leaving the host organism unaffected which can address this issue [10, 11]. Though this 
phenomenon is not directly related to E.  coli Phe sensitive DAHP synthase, understanding the 
response of E. coli DAHP to ligands will provide insight  of its allosteric interactions that can be 
associated with inhibitor designing for its other isoforms [12-14]. Therefore, the DAHP synthase 
represents an attractive molecular target for antibiotic design [15, 16]. The mechanism of DAHP 
enzyme has been extensively investigated in past years, however its conformational dynamics 
are under investigated due to lack of appropriate analytical approaches. 
The Phe sensitive DAHP synthase from E. coli is a metalloenzyme that may bind to a 
variety of metal ions at its active site and at a different stoichiometry, depending on the 
physiological conditions under which the bacteria are grown. However, the preferred metal co-
factors appear to be divalent, mainly Fe
2+
 and perhaps Zn
2+ 
though Co
2+
, Mn
2+
, Cu
2+ 
are also 
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common cofactors in E. coli DAHP synthase [17]. The metal ion plays a crucial but indirect role 
in catalysis, stabilization the conformation of the enzyme. Recent studies suggest that the metal 
ion along with the first substrate PEP, orders the secondary structure of the enzyme to assists 
binding of the second substrate E4P [18, 19]. Bonding of metal ions and/or ligands positions the 
amino acids and 7 water molecules around the active site of the enzyme with the appropriate 
geometry required to coordinate and activate the water molecule that is the third reactant of the 
condensation reaction [18, 20]. This conformational ordering is likely linked to the problem 
faced by the crystallographers in crystallizing apo-DAHP synthase [21, 22]. In fact, only metal 
binding or substrate binding can allow crystallization of DAHP under atmospheric pressure and 
low temperature. The crystallographic data demonstrate that the quaternary structure of the 
substrate or metal bound DAHP synthase consists of two tightly bound dimers suggesting that it 
exists as a tetramer (154 kDa) which is not as rigid as the bound form [8]. Our observation from 
the work described in Chapter 3 agrees with a weakly-structured, tetrameric apoprotein while the 
apo-DAHP is neither amenable to X-ray or NMR studies. HDX/TRESI-MS may represent a 
suitable approach to probe the structural changes that occur upon binding.  
This work represents an application of the continuous labelling HDX device that has 
been introduced in Chapter 3, specifically, the investigation of the structural consequences of 
ligand binding.  The device was applied to measure differential conformational response of Phe 
regulated DAHP synthase towards different ligands. Since the enzyme was grown in absence of 
metal cofactors, the observed ordering of structure reflects the conformation change caused only 
by the ligands which hasn’t been studied earlier. Using this device we have characterized 
dynamic behaviour surrounding active sites of DAHP synthase in presence and absence of 
substrate (PEP) and three inhibitors. 
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4.2 EXPERIMENTAL 
4.2.1 Materials. Pepsin agarose beads, high purity acetic acid ( 99.7%), deuterium oxide (D2O) 
and all other chemicals were obtained from Sigma (St. Louis, MO). All metal capillaries and 
PTFE tubings were purchased from McMaster-Carr (Aurora, OH). Standard 1/16″ fittings were 
purchased from IDEX Health & Science (Oak Harbor, WA).  Precut rectangular blocks (8.9 cm 
x 3.8 cm x 0.3) cm of  blank poly(methyl methacrylate) or PMMA substrate was  purchased 
from Professional Plastics (Orchard Park, NY) which was used as platform for etching micro 
channels and well (32 mm × 5 mm × 0.01 mm) using a LASER engraver (Universal Laser, 
Scottsdale, AZ).   
4.2.2 H/D Exchange Measurements. In this work, 200 μM DAHP synthase at pH 7.6 was 
mixed with its substrate phosphoenol pyruvic acid (PEP) manually and incubated for 30 min 
prior to HDX experiments. The holo protein was mixed with D2O (1:3) in the rapid mixing 
module of the device and the position of the mixer was adjusted manually to change the mixing 
time. Rest of the experimental parameters was identical to that of free DAHP synthase that has 
been described earlier in experimental section of Chapter 3.   Labeling times were varied from 
193 ms to 10 sec using flow rates of 1L/min for protein solution and 3 L/min for D2O.  
Labeling was rapidly quenched to pH 2.5 using acetic acid solution (pH 2.3) at 9 L/min prior to 
rapid proteolysis. Individual experiments were carried out in same manner using three different 
inhibitors oxime, imidazole and glycerol-3-phosohate (G3P) which is an analogue of E4P [7, 8]. 
The data analysis approach is described in details in data analysis section of Chapter 3). The 
observed HDX data were analyzed the using home built HDX software and the observed profiles 
were mapped onto its available PEP bound crystal structure (pdb 1KFL).   
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4.3 RESULTS AND DISCUSSIONS 
 
4.3.1. Comparison between apo- and PEP- bound structure. Conformational changes in 
DAHP synthase upon binding to its substrate and different inhibitors were probed via continuous 
labeling HDX experiments.  Our observation from Chapter 3 suggested that the apo DAHP 
synthase is “molten globule”-like and would need to undergo strong conformational ordering 
upon binding as there were substantial differences between the structural properties of the 
apoprotein and the ligand-bound crystal structure. In apoprotein, peptides surrounding active site 
underwent substantial exchange irrespective of the secondary structure (according to X-ray 
structure) suggesting the absence of strong hydrogen bonding that makes this regions accessible 
to deuterium. The observation from current work shows very low D uptake in those peptides and 
in good agreement with the hypothesis that we made in Chapter 3. This work proves 
experimentally the presence of a floppy secondary structural template around active sites in 
absence of any substrate in DAHP synthase. The HDX kinetics in three representative DAHP 
synthase peptides are compared between apo and PEP bound forms (Figure 4.2). In general there 
was no correlation between observed D uptake amplitude (Nfast) with number of loop residues 
(Nloop) while a better correlation was observed in the substrate bound form. The regions that 
show differences in the D uptakes are mapped on to crystal structure 1BTL (Figure 4.3) and 
colored according to the observed amplitude: navy blue (30-60), deep blue (16-30), blue (10-15), 
light blue (0-10). 
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Figure 4.2. Raw data for HDX kinetics in three representative DAHP synthase peptides. The „% 
exchanged‟ values were generated from a FORTRAN program developed in-house.  
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Figure 4.3. Differences in deuterium exchange profiles between free and PEP bound DAHP is 
mapped onto the PEP-bound 1KFL structure. The structure is colored by differences in observed 
amplitude: navy blue (30-60), deep blue (16-30), blue (10-15), light blue (0-10) 
Figure  4.4. HDX kinetics for representative peptides from apo and PEP bound DAHP synthase. 
Intrinsic rate profiles D(t)int  for each segment are shown in black. The measured profiles of apo 
and PEP bound DAHP synthase are represented by filled circles and triangle respectively and 
colored according to the extracted PF: blue (strong protection), green (moderate protection), red 
(low protection). Error measurements are based on two or three replicates depending on the 
number of experiments in which the peptide was detected. 
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c) d)
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The observed kinetics on three representative peptides is shown on Figure 4.4. Additionally, the 
observed peptides are mapped onto the available ligand-bound crystal structure 1BTL (Figure 
4.5) showing a significant difference between these two forms. This demonstrates that the device 
is capable of detecting structural differences and truly reflects the conformational information 
under any solution conditions. 
 
 
 
 
 
 
Figure 4.5. DAHP exchange profiles are mapped onto the substrate-bound 1KFL structure. (a) 
and (c) Highlighted regions correspond to peptides in which Nfast is in reasonable agreement with 
Nloop, suggesting similarity between the apo-protein structure and the PEP-bound crystal 
structure (1KFL). Many of the peptides with this property are located at the tetramer interface. 
(b) and (d) Observed peptides are mapped onto the PEP-bound DAHP structure (1KFL), colored 
by PF: blue (strong protection), green (moderate protection), red (low protection).  
c) d) 
a) b) 
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4.3.2. Conformational Analysis of Different Ligand Bound Structures. With extensive data 
analysis we were able to characterize substantial differences in dynamics near the active sites of 
the enzymes among the apo and different ligand-bound enzymes. The different structures are 
compared in terms of the D uptake amplitudes (Nfast) and protection factors (PF) exhibited by the 
peptides that are common in all five systems. The Nfast values are compared with Nloop of the 
PEP-bound form, using this structure as a baseline for comparing the conformational effects of 
different substrates and inhibitors. The observed peptides are highlighted on to the substrate-
bound 1KFL structure where the regions that are in reasonable agreement ( 20% difference) 
with Nloop (Nloop was calculated based on the PEP- bound form) and colored blue if Nfast ≤ Nloop  or  
red if Nfast ≥ Nloop  (Figure 4.6). However, the peptides on the PEP-bound form are colored blue 
as Nfast ≈ Nloop. In general the both inhibitor (oxime and imidazole) bound systems exhibits 
similar HDX profiles, taking up a relatively higher amount of D around the tetramer interface 
compared to the PEP-bound form.  This observation is also in good agreement with the previous 
crystallographic and molecular simulation studies where C61 was associated with the catalytic 
activity. Most likely enhanced flexibility in this region is linked to inhibition.   
 
Conformational flexibilities of different holo systems are also compared by calculating 
PF values where the PF of PEP bound system is considered as a base line and peptides observed 
in G3P, oxime and imidazole bound systems are mapped on to the PEP-bound 1KFL structure as 
shown in Figure 4.7. The differences in calculated protection factors are colored by: cyan 
(stronger protection than PEP), yellow-green (where PF values are within 5% agreement with PF  
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Imidazole bound DAHP Synthase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. DAHP exchange profiles mapped on to the substrate-bound 1KFL structure. 
Highlighted regions correspond to peptides in which Nfast is in reasonable agreement ( 20% 
difference) with Nloop (Nloop was calculated based on the PEP- bound form) colored blue if Nfast ≤ 
Nloop  and red if Nfast ≥ Nloop  . Figures are generated by Pymol Program,version 1.5.   
Free DAHP Synthase 
Oxime bound DAHP Synthase 
PEP bound DAHP Synthase 
G3P bound DAHP Synthase 
Free DAHP Synthase 
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values of PEP), red (low protection compared to PEP). Our data also suggests that the PEP-
bound form has high conformational flexibility near Phenylalanine binding site of the protein 
compare to the unbound protein, while binding of the inhibitor G3P induces rigidity in the same 
region. The acidic amino acids in that region probably bind strongly with the basic inhibitors and 
the smallest inhibitor imidazole causes highest structural perturbation upon binding.  
The free enzyme experiences loss of its flexibility around its active site upon binding to 
PEP which is anticipated but the response of active site towards different inhibitors is more 
complex. Other inhibitors including histidine and a structurally-related oxime apparently bind to 
the active site, but fail to induce the development of structure in the enzyme as a whole, as 
occurs with PEP and G3P. We have observed opposite dynamics around two different PEP 
binding sites upon G3P binding irrespective of its structural similarities to PEP. The basic 
inhibitors imidazole and oxime show similar reduced dynamics around these two sites even 
though in general these two inhibitors retain conformational flexibility upon binding compared 
to PEP and G3P. 
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Imidazole bound DAHP Synthase 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. The differences in calculated protection factors are mapped on to the PEP-bound 
1KFL structure where the PF of PEP bound system is considered as a base line. The structure is 
colored by: cyan (stronger protection than PEP), yellow-green (where PF values are within 5% 
agreement with PF values of PEP), red (low protection compared to PEP).  
 
G3P bound DAHP Synthase 
Oxime bound DAHP Synthase 
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4.4 CONCLUSIONS 
This work successfully demonstrates the application of continuous labeling TRESI/HDX 
device as a suitable approach for studying conformational changes in enzymes that occur upon 
ligand binding.  The device enabled us to compare structural ordering of DAHP synthases 
around its active sites and tetramer interfaces caused by ligand (substrate and different 
inhibitors) by comparing Nloop with Nfast and protection factors (PF) values of apo and different 
holo enzymes. However, we were unable to probe the asymmetric binding of the ligands on 
different subunits of the tetramer, which has been proposed as an explanation for cooperative 
behavior observed during catalysis (unpublished). Therefore, we aim to measure global HDX 
profile of tetramer with response to all of these small molecules (substrates/ inhibitor) followed 
by rapid degradation (initiated by a pH jump from 7.0-2.5) into individual monomers prior to 
ionization. This proposed experiment can provide us information about the asymmetric binding 
of the subunits and eventually will be beneficial in finding differential dynamic behavior of 
individual monomers.  This study constitutes the dynamic analysis of substrate binding on 
DAHP synthase and provides insight into questions that may offer valuable input for the design 
of novel enzyme inhibitors. 
 
 
 
 
 
121 
 
REFERENCES 
 
1. Bentley, R. and E. Haslam, The Shikimate Pathway â€” A Metabolic Tree with Many Branche. 
Critical Reviews in Biochemistry and Molecular Biology, 1990. 25(5): p. 307-384. 
2. Herrmann, K.M., The shikimate pathway as an entry to aromatic secondary metabolism. Plant 
Physiol, 1995. 107(1): p. 7-12. 
3. Herrmann, K.M., The Shikimate Pathway: Early Steps in the Biosynthesis of Aromatic 
Compounds. Plant Cell, 1995. 7(7): p. 907-919. 
4. Herrmann, K.M. and L.M. Weaver, THE SHIKIMATE PATHWAY. Annu Rev Plant Physiol Plant Mol 
Biol, 1999. 50: p. 473-503. 
5. Herrmann, K. and R. Entus, Shikimate Pathway: Aromatic Amino Acids and Beyond, in eLS. 2001, 
John Wiley & Sons, Ltd. 
6. Halsall, D.M. and C.H. Doy, Studies concerning the biochemical genetics and physiology of 
activity and allosteric inhibition mutants of Neurospora crassa 3-deoxy-d-arabino-heptulosonate 
7-phosphate synthase. Biochimica et Biophysica Acta (BBA) - Enzymology, 1969. 185(2): p. 432-
446. 
7. Furdui, C., et al., Insights into the mechanism of 3-deoxy-D-arabino-heptulosonate 7-phosphate 
synthase (Phe) from Escherichia coli using a transient kinetic analysis. J Biol Chem, 2004. 
279(44): p. 45618-25. 
8. Konig, V., et al., Substrate and metal complexes of 3-deoxy-D-arabino-heptulosonate-7-
phosphate synthase from Saccharomyces cerevisiae provide new insights into the catalytic 
mechanism. J Mol Biol, 2004. 337(3): p. 675-90. 
9. Muday, G.K. and K.M. Herrmann, Wounding Induces One of Two Isoenzymes of 3-Deoxy-d-
arabino-Heptulosonate 7-Phosphate Synthase in Solanum tuberosum L. Plant Physiol, 1992. 
98(2): p. 496-500. 
122 
 
10. Dyer, W.E., et al., Wounding induces the first enzyme of the shikimate pathway in Solanaceae. 
Proc Natl Acad Sci U S A, 1989. 86(19): p. 7370-3. 
11. Helmstaedt, K., et al., Evolution of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase-
encoding genes in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A, 2005. 102(28): 
p. 9784-9. 
12. Schoner, R. and K.M. Herrmann, 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase. 
Purification, properties, and kinetics of the tyrosine-sensitive isoenzyme from Escherichia coli. J 
Biol Chem, 1976. 251(18): p. 5440-7. 
13. Jensen, R.A. and S. Ahmad, Evolution and phylogenetic distribution of the specialized isozymes of 
3-deoxy-D-arabino-heptulosonate 7-phosphate synthase in superfamily-B prokaryotes. Microbiol 
Sci, 1988. 5(10): p. 316-9. 
14. Berry, A., J.L. Johnson, and R.A. Jensen, Phenylalanine hydroxylase and isozymes of 3-deoxy-D-
arabino-heptulosonate 7-phosphate synthase in relationship to the phylogenetic position of 
Pseudomonas acidovorans (Ps. sp. ATCC 11299a). Arch Microbiol, 1985. 141(1): p. 32-9. 
15. Jiao, W., et al., Dynamic cross-talk among remote binding sites: the molecular basis for unusual 
synergistic allostery. J Mol Biol, 2012. 415(4): p. 716-26. 
16. Xu, X., et al., Structure-based design of novel inhibitors of 3-deoxy-D-manno-octulosonate 8-
phosphate synthase. Drug Des Discov, 2003. 18(2-3): p. 91-9. 
17. Stephens, C.M. and R. Bauerle, Analysis of the metal requirement of 3-deoxy-D-arabino-
heptulosonate-7-phosphate synthase from Escherichia coli. J Biol Chem, 1991. 266(31): p. 20810-
7. 
18. Shumilin, I.A., et al., Crystal Structure of the Reaction Complex of 3-Deoxy-d-arabino-
heptulosonate-7-phosphate Synthase from Thermotoga maritima Refines the Catalytic 
Mechanism and Indicates a New Mechanism of Allosteric Regulation. Journal of Molecular 
Biology, 2004. 341(2): p. 455-466. 
123 
 
19. Shumilin, I.A., et al., Allosteric Inhibition of 3-Deoxy-d-arabino-heptulosonate-7-phosphate 
Synthase Alters the Coordination of Both Substrates. J. Mol. Biol., 2002. 320(5): p. 1147-1156. 
20. Muday, G.K., The role of DAHP synthase isozymes in control of carbon flow into the shikimate 
pathway in bacteria and plants, in ProQuest Dissertations and Theses1989, Purdue University: 
United States -- Indiana. p. 120-120 p. 
21. Schneider, T.R., M. Hartmann, and G.H. Braus, Crystallization and preliminary X-ray analysis of 3-
deoxy-D-arabino-heptulosonate-7-phosphate synthase (tyrosine inhibitable) from 
Saccharomyces cerevisiae. Acta Crystallogr D Biol Crystallogr, 1999. 55(Pt 9): p. 1586-8. 
22. Webby, C.J., et al., Crystallization and preliminary X-ray crystallographic analysis of 3-deoxy-D-
arabino-heptulosonate-7-phosphate synthase from Mycobacterium tuberculosis. Acta 
Crystallogr Sect F Struct Biol Cryst Commun, 2005. 61(Pt 4): p. 403-6. 
 
 
124 
 
 
CHAPTER 5 
An Electrospray MS-coupled Microfluidic Device for Sub-second 
Hydrogen/Deuterium Exchange Pulse-labelling Reveals Allosteric Effects in 
Enzyme Inhibition 
Adapted from Lab on a Chip. 2013, special issue (10.1039/C3LC00007A) 
5.1 INTRODUCTION 
 
  With the emergence of 'soft' ionization techniques for mass spectrometry in the late 
1980's microfluidics was quickly recognized as a means to link rapid, precise sample handling 
with the analytical power of mass spectrometry [1-5]. Electrospray is the soft ionization method 
most-often coupled to microfluidics owing mainly to the direct transfer from solution to the gas 
phase. Numerous Electrospray Coupled Microfluidic Devices (ECMDs) have been introduced 
using a range of substrates including polymer, silicon and glass, with the most common 
application being proteomics [6-11]. The intense academic interest in ECMDs has translated now 
to industry, and there are a growing number of commercial devices on the market for use in 
proteomics [12].  However, ECMDs remain underdeveloped for other applications to which they 
are ideally suited. Experiments to monitor protein structure, dynamics and function, for example, 
which are increasingly needed to support the shift to 'biologics' in the pharmaceutical industry, 
benefit greatly from implementation on an ECMD platform, but only a handful of such devices 
have been devised [13, 14]. 
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  In HDX experiments, analytes with solvent-exchangeable protons are exposed to D2O 
resulting in the incorporation of deuterium into the molecule. This process can be monitored by 
NMR or mass spectrometry, with mass spectrometry being the more versatile (though at times 
less informative) approach [15]. In the context of proteins, HDX is a measure of solvent 
accessibility and strength of hydrogen bonding (hydrogen bonds must break in order for 
exchange to occur) for 'backbone' amide protons [16]. Since secondary structure is maintained by 
a network of backbone hydrogen bonds, the occurrence of HDX (or rather the lack of it) can be 
used to identify regions of rigid secondary structure [17]. Additionally, the rate of exchange can 
be used as a quantitative or semi-quantitative measure of structural stability, more commonly 
understood as protein dynamics [18]. 
 
  In an intact protein, HDX is observed by mass spectrometry as a shift to higher mass that 
occurs at a certain rate. This 'global' measurement is a facile way to predict overall protein 
structural stability and is particularly useful for characterizing the structural consequences of 
ligand binding [19]. However, in order to determine which regions of the protein are dynamic, it 
is necessary to fragment the labelled protein into peptides whose individual deuterium uptake 
levels can be linked back to their positions within the native structure. This fragmentation can be 
achieved after ionization using 'non-ergodic' techniques like electron capture dissociation ('top-
down'), or before ionization by quenching the exchange process and digesting with an acid-
resistant protease ('bottom-up') [17, 20]. Of these approaches, 'bottom-up' provides somewhat 
less spatial resolution, but is applicable to a much broader range of proteins and does not require 
expensive, specialized equipment. HDX experiments can be conducted in a continuous or pulse 
labelling regime. In the continuous regime, the protein is exposed to D2O for a variable length of 
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time, allowing the rate of deuterium uptake to be measured. In pulse labelling experiments, a 
reaction involving the protein is initiated and allowed to progress for a variable time before 
exposure to a fixed-length D2O labelling pulse. This approach is suitable for following structural 
changes that occur during a reaction, most commonly protein folding [21-23]. Alternatively, 
pulse labelling might be used to reveal the structural changes associated with slow allosteric 
effects after ligand or inhibitor binding. 
 
  In this study, we introduce a microfluidic device that enables the complete workflow for 
bottom-up HDX pulse labelling experiments. The device incorporates a variable-position 
micromixer for adjustable reaction-time mixing, a static micromixer and delay volume 
generating a fixed 46 ms D2O labelling pulse, a subsequent mixer for HDX quenching and a 
pepsin-functionalized microreactor for efficient protein digestion prior to on-chip ESI. We use 
this device to investigate the structural changes that occur upon acylation of the beta lactamase 
enzyme TEM-1 by a covalent inhibitor. Our results reveal several rapid structural changes near 
the active site and more subtle changes that occur over several seconds in active-site remote 
regions. 
 
5.2 EXPERIMENTAL 
5.2.1 Materials. Pepsin agarose beads, high purity acetic acid ( 99.7%), deuterium oxide 
(D2O), ammonium bicarbonate (99.8%) and potassium clavulanate were purchased from Sigma 
(St. Louis, MO). Ultrapure water was generated in-house on a Millipore Milli-Q Advantage A10 
system. Polyimide coated glass capillaries (O.D. 153 m, I.D. 75 m) were purchased from 
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Polymicro Technologies (Pheonix, AZ). Metal capillaries (O.D. 400 m, I.D. 200 m and O.D. 
318 m, I.D. 177.8 m) and PTFE tubing (O.D. 1/16″, I.D. 400 m and O.D. 1/16″, I.D. 205 
m) were supplied by McMaster-Carr (Aurora, OH). Standard 1/16″ Upchurch fittings were 
purchased from Scientific Products & Equipment (North York, ON).  Blank poly(methyl 
methacrylate) or PMMA substrate was  purchased from Professional Plastics (Orchard Park, NY) 
in rectangular  block with  dimension 8.9 cm x 3.8 cm x 0.3 cm.  A dremel (Craftsman Co. 
Hoffman Estates, IL) was used to sharpen the metal capillary for ESI. 
 
5.2.2 Device Fabrication.  The microfluidic chip was fabricated from polymethyl methacrylate 
(PMMA) as described previously in details in chapter 2. Briefly, the microfluidic channels were 
etched on PMMA using a VersaLaser™ engraver (Universal Laser, Scottsdale, AZ) with a 
slightly defocussed laser to generate square channels that is described in details in Chapter 2. A 
proteolytic reactor surface was generated by etching closely spaced 30 µm deep channels in a 
hashed pattern within a rectangular area (25 mm x 5 mm). These micro channels generated a fine 
mesh of lines for the reactor bed where pepsin beads (average diameter 20 µm) were physically 
trapped in the grooves. Another blank PMMA block was used as a celling, forcing liquid 
entering the reactor through the pepsin-filled grooves [24]. Parafilm was used as gasket to 
obtain liquid-tight seal between the two PMMA blocks.  A custom built clamp was obtained 
from LAC Machine & Tooling Limited, ON to pressure-seal the microfluidic device. 
Connections to the outside world were made by melting metal capillaries into channels running 
off the side of the chip [25]. 
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  The device is shown in Figure 5.1. It consists of three inlet channels, the center one 
incorporating an adjustable position capillary mixer for variable-time incubation of TEM-1 with 
clavulanate from 128 ms to 9 s. D2O and acetic acid were mixed in using a 4 mm long sealed 
polyimide-coated glass capillary which acted to force reactant solutions together through the 
narrow regions between the capillary and the channel walls (maximum 7 µm). All fluids were 
infused into the microfluidic device using infusion pumps (Harvard, Holliston, MA) with 
standard Upchurch fittings. 
 
5.2.3 TEM-1 Purification. TEM-1 purification has been described previously [26]. Briefly, E. 
coli BL21(DE3) carrying the plasmid pET24 a+ were grown overnight in Luria Bertani medium 
supplemented with 30 μg/ml kanamycin. Grown cultures were diluted 100-fold in Terrific Broth 
medium, containing 30 μg/ml kanamycin, 0.4 M D-Sorbitol and 2.5 mM betaine. Cells were 
grown by shaking at 37 ºC until Optical Density (at 600 nm) of 0.6 was reached. At this point 
TEM-1 over-expression was induced by adding isopropyl β-D-thiogalactopyranoside (IPTG) for 
a final concentration of 0.4 mM. Cells were made to over-express the protein overnight at 25 ºC. 
After pelleting the cells by centrifugation, the supernatant was collected. TEM-1 was purified by 
cation exchange as described previously [26]. 
 
5.2.4 HDX Measurements. HDX pulse labelling was carried out on TEM-1 using the 
microfluidic chip as a custom electrospray ionization (ESI) source. The chip was directly 
interfaced with a modified QSTAR® Elite hybrid quadrupole time-of-flight (QqTOF) mass 
spectrometer (Sciex, MDS Analytical Technologies, Concord, ON).  20 M TEM-1 was mixed 
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with potassium clavulanate (1:1) in the rapid mixing module of the device (pH 7.84). The 
position of the mixer in the mixing module was adjusted manually to control the incubation time. 
Using flow rates of 3L/min for protein solution and 3 L/min for potassium clavulanate, we 
were able to achieve mixing times from 128 ms to 9 s. A flow rate of 3L/min for D2O 
facilitated a 46 ms D2O labelling pulse prior to a rapid HDX quenching by dropping the pH to 
2.6 using a 4% acetic acid solution (pH 2.3) at 10 L/min. Subsequent digestion of the labelled 
protein and transfer to ESI was achieved in approximately 6 s using the microfluidic reactor, 
resulting in undetectable back exchange of backbone protons (exchangeable protons on side 
chains and peptide N-termini undergo rapid back-exchange and are assumed to be 16% labelled, 
having equilibrated with the final solution H2O/D2O ratio prior to electrospray). 
 
5.2.5 Mass Spectrometry. ESI-MS experiments were carried out on a QStar Elite quadrupole 
time-of-flight (Q-TOF) instrument (MDS Analytical Technologies, Concord, ON, Canada) with 
a custom-built source assembly. A switch was used to simulate the presence of the commercial 
source. Optimal running conditions of +5000 V to +4800 V source, 60 V declustering potential, 
and focusing potential of 250 V were achieved through the positioning of the electrospray tip on 
a vertically adjustable stage. All analyses were carried out in positive ion mode and at acquisition 
rates of 1s−1. The samples were scanned over the 250–1500 m/z range. 
 
 
5.2.6. Data Analysis. Data were analysed using an in-house built program introduced previously 
in Chapter 3 [13]. Briefly, HDX incorporation levels for each peptide were determined by fitting 
the observed isotopic distribution to a theoretical one generated by convolution of the natural 
isotope distribution with the deuterium label distribution associated with a particular level of 
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exchange. A least-squares approach was used to determine which level of exchange (expressed 
as % label) agreed best with the observed isotopic distribution. Adjustments are made for the 
rapid equilibration of exchangeable protons on side-chains and the N-terminus with the final 
electrosprayed solution (which was 16% D2O). Given the short length of the labelling pulse, 
HDX is expected to occur to a significant degree only in unstructured regions of the protein. We 
can therefore define an expected level of exchange Nloop for each peptide based on the number 
amides that are in a loop configuration in the crystal structure. Significant deviations from Nloop 
in the % label value suggest changes in structure and/or dynamics compared to the crystal 
structure (in this case in response to acylation). 
 
5.3 RESULTS AND DISCUSSIONS 
 
5.3.1 Device Performance. In bottom-up HDX pulse labeling experiments, there are a number 
of important metrics for performance. From the perspective of microfluidics, the first of these is 
mixing efficiency and control. The capillary mixer used to initiate the acylation of TEM-1 has 
been extensively tested in earlier work [25, 27, 28] and is known to provide complete mixing 
within 5 ms. The static mixer used in the next two mixing steps (D2O and 4% acetic acid) is less 
well characterized, but based on the predicted time for a mean displacement of 7 µm for protons 
(D  5  10-9 m2s-1 after a crude adjustment for the presence of 16% D2O), complete mixing of 
should occur within 17 ms, which is well within the residence time of the mixer (approx. 25 ms). 
In practice, no experimental artifacts that might be attributed to inefficient or poorly controlled 
mixing were observed. Poor mixing of D2O, for example, would have resulted in lower than 
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expected deuteration levels on all peptides while poor mixing of acid would have resulted in 
rapid back exchange and inactivation of pepsin in the reactor well. 
 
  The second critical performance factor is spatial resolution, which in bottom-up 
experiments is effectively a measure of digestion efficiency. In general, the more peptides 
generated in the digestion step, the more specific the analysis in terms of where on the protein 
deuterium uptake is occurring. Our device provides relatively low digestion efficiency compared 
to conventional LC-based techniques, but operates at a much faster rate (≤ 6 s) which greatly 
reduces back-exchange. Ultimately the analysis was conducted with 28 peptides corresponding 
to 65% sequence coverage and an average spatial resolution of 8.5 residues. While there is room 
for improvement of these numbers, this level of spatial resolution was more than sufficient to 
provide some interesting insights into the changes in TEM-1 dynamics that occur as a 
consequence of inhibitory acylation. A complete list of peptides is provided in table 5.1. 
 
5.3.2 Changes in TEM-1 Dynamics on Acylation. The TEM-1/clavulanate system was selected 
to demonstrate our apparatus in part because of the putative critical role of dynamics in the 
inhibitory mechanism [26]. In our pulse labeling experiments, the raw data are in the form of 
isotopic distributions associated with each peptide (Figure 5.2). Changes in these distributions 
are linked to the amount of deuterium acquired by the peptide, which we express as '% labeled' 
in order to normalize for the number of available sites on peptides of different length. Figure 5.2 
shows time-dependent profiles for four peptides, each representing one of the behaviors 
observed in the broader data set. 
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Table 5.1:  All observed peptides with HDX levels, pre-mixing and two time-points post-
mixing with clavulanate. 
Sequence position Free enzyme  
128 ms 
(% labeled) 
Acyl-enzyme  
128 ms 
(% labeled) 
Acyl-enzyme 
 9.0 s 
(% labeled) 
HPETL 001-005 15 15 15 
HPETLVKVKDAEDQLGARVG 
Y 
001-021 3 6 22 
VKVKDAEDQLGARVGY 006-021 5 19 19 
VKVKDAEDQLGARVGY 006-021 4.5 19 19 
AEDQLGARVGYI 011-022 2 6 27 
IELDLNSGKILESF 022-035 14 12 6 
LDLN 024-027 10 14 31 
NSGKILESFRPEE 027-039 6 4 4 
SRVDAGQEQLGRRIHYSQND 
L 
057-077 15 11 11 
GRRIHYSQNDL 067-077 14 20 20 
SDNTAANL 105-112 4 7 7 
SDNTAANLLLTTI 105-117 9 8 5.5 
TTIGGPKELTAF 115-126 7 3 3 
FLHNMGDHVTRL 126-137 16 10 10 
FLHNMGDHVTRL 126-137 12 8 8 
HNMG 128-131 10 7 7 
DRWEPEL 138-144 6 6 6 
RKLLTGEL 166-173 11 11 20 
IDWMEA 183-188 2 7 7 
DKVAGPLL 189-196 0 1 7 
PAGWFIA 201-207 2 4 4 
GWFIADKSG 203-211 18 18 18 
GWFIADKSGAGERGSRGIIA 
ALGPDGKPSRIVV 
203-235 6 12 12 
FIADKSGAGERGSRGIIAA 205-223 5 10 10 
YTTG 237-240 6 6 6 
DERNRQIAE 246-254 8 5 5 
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  A number of peptides did not exhibit any change in deuterium uptake immediately 
following acylation nor up to 9 s after acylation. These peptides denote regions of TEM-1 that do 
not undergo a significant change in dynamics or solvent accessibility upon acylation of the 
protein by clavulanate. The majority of peptides were observed to undergo a significant, rapid 
change in deuterium uptake upon acylation, with increases and decreases in roughly equal 
proportion. A rapid increase in deuterium uptake would imply that acylation makes the region in 
question more dynamic, while a decrease in uptake indicates a 'tightening up' of the structure or a 
decrease in solvent accessibility due to the presence of inhibitor. Most interesting, however, are 
the peptides that undergo slow changes in deuterium uptake after acylation. These peptides may 
correspond to regions of the protein that undergo functionally relevant allosteric transitions upon 
inhibition. 
 
  These behaviors can be analyzed kinetically to determine the rate at which the changes in 
dynamics occur after acylation. Kinetic plots for three peptides are shown in Figure 5.3. The 
dotted line shows the expected level of exchange based on the crystal structure, Nloop. Error bars 
are based on up to four transients, depending on the number of data sets in which the peptide was 
observed. Rates extracted from single exponential fits to the data are identical, indicating that the 
allosteric changes in dynamics occur at more-or-less the same rate after acylation. 
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Figure 5.3. A kinetic analysis of the changes in dynamics associated with acylation. The dotted 
line represents the expected level of exchange based on the crystal structure. Error bars are based 
on up to 4 transients, depending on the number of data sets and time-point in which the peptide 
was observed.  
 
 
  Ultimately, the pulse labeling data can be mapped onto the crystal structure to rationalize 
the observed structural and dynamic changes. Figure 5.4 (a) shows the changes that take place 
immediately on binding. Red indicates an increase in HDX upon acylation, blue a decrease and 
green denotes no change. One general observation of note is that the majority of peptides that 
exhibit exclusively rapid changes are in structured regions of the protein core, particularly the 
beta sheet that lies at the 'top' of the active site in Figure 5.4.  
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active site. This suggests that the changes observed may be related to allosteric effects associated 
with acylation by clavulanate.  Support for this rationalization is provided by high frequency 
random mutagenesis studies, in which a number of peripheral mutations have been shown to 
strongly influence enzyme activity [31, 32]. This includes mutations at positions 42, 104 and 
164, all of which are identified in our data as being in or close to regions that undergo 'allosteric' 
changes in dynamics due to acylation.  
 
5.4 CONCLUSIONS 
  In summary, we have introduced an integrated microfluidic device that houses the 
complete workflow for 'bottom-up' HDX pulse labelling experiments. This device is 
complementary to a continuous labelling HDX chip introduced earlier [13] and is uniquely well 
suited to probe allosteric changes occurring as a consequence of covalent modification (e.g. 
phosphorylation, covalent inhibition etc.) or ligand binding. To demonstrate the utility of the 
approach, we applied our device to covalent inhibition of the beta-lactamase enzyme TEM-1 by 
clavulanate. Even in the straightforward and inexhaustive experiments conducted, we were able 
to measure changes in structure and dynamics directly linked to inhibition and to identify 
peripheral regions of the protein where allosteric effects occur, many of which contain residues 
known to influence catalytic efficiency. To our knowledge, these data represent the first 
experimental analysis of TEM-1 acyl-enzyme dynamics and provide an entirely new way to 
predict allosteric modulation of catalytic activity. Ultimately, we expect this approach will prove 
a facile and powerful tool for understanding the structural and dynamic changes that accompany 
functional processes in proteins. 
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CHAPTER 6 
Application of Microfluidics to the Prediction of Allosteric Sites in  
TEM-1 Beta-lactamase  
6.1 INTRODUCTION 
   
  Antibiotic resistance is currently a major health concern in treating infectious diseases. 
The production of Beta-lactamase enzymes (β-lactamases) is the main cause of this resistance 
which act by destroying the beta-lactam structure of antibiotics before they reach the bacterial 
target [1, 2]. Clinical usages of antibiotics are continuously challenged with the emergences of 
new beta lactamases, sometimes as soon as the new antibiotics are introduced. To address this 
issue, enormous efforts scientists have been made to investigate β-lactamase structure and 
mechanisms for the development of uncleavable drugs and/or inhibitors. β-lactam antibiotics 
contain a beta lactam ring which is the preferred target of beta lactamases, rendering the drugs 
inert upon hydrolysis (Figure 6.1) [3, 4]. β-lactam antibiotics can be classified into two major 
categories: first generation and second generation antibiotics (also known as extended structure 
antibiotics) that contain a five member ring and six member ring along a beta lactam core. First 
generation antibiotics are extremely susceptible targets of most of the naturally evolved β-
lactamases while the extended structures exhibit better effectiveness against same β-lactamases. 
For a better clinical performance of these antibiotics, they are usually combined with a β-
lactamases inhibitor [5, 6]. However, inhibitor usage has also been challenge due to the 
emergence of inhibitor resistance.  
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Figure 6.1. Inactivation mechanism of β-lactam ring by β-lactamases via acylation and deacy 
lation.  
 
  The β-lactamases are traditionally classified based on either functional characteristics or 
their amino acid sequence, the latter of which is known as molecular classification. Based on 
conserved and distinguishing amino acid motifs, β-lactamases are classified into four molecular 
classes, A, B, C, and D. Enzymes which utilize an serine residue for hydrolysing  β-lactam ring 
whereas class B are metalloenzymes which require at least one active-site divalent zinc ions to 
facilitate β-lactam hydrolysis [3, 7]. In 1995  Bush et al. proposed another functional 
classification scheme that takes into account substrate and inhibitor profiles in an attempt to 
group the enzymes in ways that can be correlated with their phenotype in clinical isolates [8]. 
TEM-1 is one of the most commonly encountered antibiotic resistant species causeing up to 90% 
of ampicillin resistance in E. coli. TEM-1 is classified as class A broad-spectrum β-lactamases 
according to Molecular classification, while it belongs to functional subgroup 2b.  It readily 
hydrolyzes penicillins and early cephalosporins, such as cephaloridine and cephalothin to 
inactivate them while the resistance can be strongly inhibited by clavulanic acid and tazobactam.  
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  Although TEM-1 beta-lactamase is one of the most studied enzymes, its catalytic 
mechanism still remains controversial [9]. Numerous independent approaches have been taken to 
resolve this issue, for instance by ultrahigh resolution X-ray crystallography or molecular 
dynamics simulations. Some of these studies afforded a detailed view of the structure, dynamics 
and hydrogen bonding networks of TEM-1 which provided details about the acylation 
mechanism. The acylation of TEM-1 by β-lactam compound is modelled as a two-step 
mechanism where the first step   involves activation of catalytic serine residue (Ser70) to cleave 
the lactam ring [1, 10-12] . A 70 SXXK motif is identified as the essential component in most of 
the β-lactamases, demonstrating that the close proximity of the Ser (S) and Lys (K) are crucial 
for acylation [13]. A dynamic loop has also been identified where the Glu166 positions an active 
site water molecule which forms bond with Ser70 [14, 15]. This water molecule does not 
exchange with bulk solvent, emphasizing its structural and catalytic relevance. In the presence of 
the substrate Ser130, Ser235, and Arg244 directly interact with the beta-lactam carboxylate via 
H-bonds, whereas the Lys234 ammonium group and Ser238 hydroxyl group have only an 
electrostatic influence [16]. However, these interactions together with other specific contacts 
result in a very short distance (approximately 3 ᵒA) between the attacking hydroxyl group of 
Ser70 and the β-lactam ring carbonyl group, which is a favourable orientation for nucleophilic 
attack [14, 17-19]. 
 
  TEM-1 has shown a perplexing functional flexibility via 'natural' evolution in response to 
the introduction of novel drugs derived from these antibiotics. Since its discovery in the 1960s, 
over 170 variants of TEM-1 with different amino acid sequences and often resistance phenotypes 
that include extended structure β-lactamases (ESBL) as well - have been isolated in hospitals and 
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clinics worldwide [20-22] However, most commonly encountered single amino acid 
substitutions are observed at positions 104, 164, 237- 240 both as individual and as 
combinatorial substitutions (associated with the ESBL phenotype) [23-25]. In bacteria and 
viruses where the spontaneous mutation rate is often high and the generation time is short, the 
rapid emergence of drug –resistant organisms has created a problem for the use and development 
of antibiotics. In response to the selective pressure of drug exposure amino acid substitutions that 
alter the specificity of the drug target accumulate and confer a selective advantage when the 
antibiotic is encountered [21, 26]. A puzzling phenomenon has been the accumulation of 
additional mutations that do not appear to confer a selective advantage by altering substrate 
specificity. A plausible hypothesis is that these secondary mutations compensate for the defects 
in catalytic activity or enzyme stability arising from specificity altering primary mutations.
   
  This work demonstrates an application of the HDX pulse labelling microfluidic device 
that was introduced earlier in chapter 5. Following a parallel experimental approach, we use this 
device to compare the structural changes and time dependent allostery that occur on the beta 
lactamase enzyme TEM-1 upon binding to its covalent inhibitor, a good substrate and a poor 
substrate. Our results show that TEM-1 responds differently towards its different substrates or 
inhibitor which is expected but their highly dynamic regions carries the residues that are either 
important sites for its biological function or where the mutation occurs naturally. This 
remarkable correlation demonstrates the potential of the device in predicting possible sites of 
functionally relevant mutations. 
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6.2 EXPERIMENTAL 
6.2.1 Materials. Ampicillin, cephalexin, potassium clavulanate, pepsin agarose beads, high 
purity acetic acid ( 99.7%), deuterium oxide (D2O), ammonium bicarbonate (99.8%) and all 
other chemicals were obtained from Sigma (St. Louis, MO). Polyimide coated glass capillaries 
(O.D. 153 m, I.D. 75 m) were purchased from Polymicro Technologies (Pheonix, AZ). All 
metal capillaries and PTFE tubings were purchased from McMaster-Carr (Aurora, OH). 
Standard 1/16″ fittings were purchased from IDEX Health & Science (Oak Harbor, WA).  Precut 
rectangular blocks (8.9 cm x 3.8 cm x 0.3) cm of blank poly(methyl methacrylate) or PMMA 
substrate was  purchased from Professional Plastics (Orchard Park, NY). 
 
6.2.2 Microfluidic Device Fabrication. Device fabrication has been discussed in details in 
chapter 5. Briefly, we followed the exact fabrication protocol but instead of a  4mm long closed 
polyimide-coated glass capillary, we have used a 4 mm long closed metal capillary (O.D. 153 
m) as a static mixer to ensure efficient mixing of  holo protein and D2O within a small volume 
of    n    nother metal capillary was added 6 mm downstream of the D2O channel to introduce 
acid for quenching the HDX reaction before transferring the solution to proteolytic module.   
  
6.2.3 TEM-1 purification. TEM-1 protein was purified following the same purification protocol 
that has been described in Chapter 5. 
 
6.2.4 H/D Exchange Measurements.  HDX studies were carried out with TEM-1 using the 
pulse labelling microfluidic chip as custom electrospray ionization (ESI) source keeping 
identical front end mass spectrometer condition that had been described in Chapter 5.  100 M 
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TEM-1 (pH 7.92) was mixed with one of its good substrate ampicillin (1:1) in the variable 
position mixing module of the device. Flow rates of 3L/min for protein solution and 3 L/min 
for Ampicillin enabled us to modulate mixing times from 128 ms to 10 sec. In separate 
experiments, cephalexin or potassium clavulanate was used instead of ampicillin. All other 
experimental parameters were identical to the parameters used in experimental section of chapter 
5 and same approach was applied in data analysis as well. 
 
6.3 RESULTS AND DISCUSSIONS.  
In Chapter 5, we have demonstrated the potential of the pulse labeling device in 
monitoring allosteric changes that enabled us to detect time dependent change in dynamics of 
TEM-1/clavulanate system. We have now extended that work to measure differential allosteric 
behavior of TEM-1 in response to three different ligands: ampicillin (a good substrate), 
cephalexin (poor substrate) and K-clavulanate (inhibitor) [20, 23]. Ampicillin is a very good 
substrate of    -1 that readily undergoes hydrolysis with  an extremely fast turnover rate    1 8) 
whereas hydrolysis of cephalexin is relatively slower suggesting that there might be significant 
differences in their dynamics in the pre-acylation step [14, 27]. Since clavulanate does not 
undergo hydrolysis but shows allostery, the observed dynamics of TEM-1/cephalexin and TEM-
1/ampicillin systems were compared with a refined data set of TEM-1/clavulanate system. The 
observed isotopic distributions were analyzed following the same protocol that has been 
discussed in details in results and discussion section of Chapter 5. We have adopted same 
coloring scheme to map the dynamic changes on to the crystal structure but instead of 1BTL 
(ligand free) we have used 1FQG crystal structure which is a substrate bound structure of TEM-
1. 
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As expected, TEM-1 demonstrates very different conformational behavior towards its 
substrates and inhibitor. In some cases, the changes in deuterium distributions by observed 
peptides in three different systems are somewhat similar. However, there are some key regions 
that show opposite behaviors  in terms of ‘tightening’ or ‘loosening’ of structure) in deuterium 
uptake either after immediate binding (acylation) or 10 s after acylation. Interestingly, most of 
these regions correspond to the functional regions of the enzyme that are relevant to its catalytic 
activity. The structural changes that occur in three different systems of TEM-1 are compared by 
analyzing the kinetics of changes in dynamics, i.e. how fast the dynamics are changing in 
response to ligand binding.  Kinetic plots of peptides under the three different system conditions 
are compared to determine the rate at which they respond towards the ligands. Kinetic plots for 
three important peptides are shown in Figure 6.2, 6.3 and 6.4. Additionally, the observed 
deuterium uptakes are listed on table 6.1, 6.2 and 6.3. 
 
The most interesting behavior was exhibited by the peptide ‘DRWEPEL’ which is 
considered as a dynamic active loop and situated around the active site periphery (Figure 6.2 a). 
This peptide contains the active residue Glu164 that is involved in acylation mechanism [20, 23]. 
The peptide does not experience any structural change upon binding to inhibitor, but undergoes 
rapid fluctuation after binding as well show allosteric interactions to ampicillin or cephalexin. 
Surprisingly, in case of the poor substrate cephalexin, the observed deuterium level is 33% 
(maximum D uptake observed in this experiment) but with a slower rate while it takes only 12% 
deuterium with an abrupt rate for the good substrate ampicillin.  
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Table 6.1:  All observed peptides with HDX levels, pre-mixing and two time-points post-
mixing with ampicillin. 
Sequence position Free enzyme 
128 ms 
(% labeled) 
Acyl-enzyme 
128 ms 
(% labeled) 
Acyl-enzyme 
10.0 s 
(% labeled) 
HPETL 026-030 10 15 33 
HPETLVKVKDAEDQLGARVG Y 026-046 1 15 33 
SFRPEE 059-064 0 8 8 
VLLCGAVLSRVDA 074-086 0.05 16 32 
SRVDAGQEQLGRRIHYSQNDL 082-102 10 2.5 2 
SDNTANLLLTTI  130-142 0 0 0 
ANLLLTTI TTIGGPKEL 135-148 0 2 6 
DRWEPEL 161-167 0 12 12 
LRKLLTGELLTLASRQQLIDWE 188-210 12 0 0 
ATTLRKLLTG 185-194 0 5 28 
RKLLTGEL 191-198 5 15 33 
RKLLTGELL 191-199 5 12 33 
IDWMEA DKVAGPLLRSALPAGW 208-229 2 16 16 
DKVAGPLL 214-221 2 9 24 
GWFIADKSGAGERGSRGIIA 
ALGPDGKPSRIVV 
228-260 6 12 12 
FIADKSGAGERGSRGIIAALG 230-248 0 8 33 
IAEIGAS 275-281 0 16 18 
IGASL 280-284 0 6 33 
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Table 6.2:  All observed peptides with HDX levels, pre-mixing and two time-points post-
mixing with cephalexin. 
 
Sequence position Free enzyme 
128 ms 
(% labeled) 
Acyl-enzyme 
128 ms 
(% labeled) 
Acyl-enzyme 
10.0 s 
(% labeled) 
HPETL 026-030 10 10 30 
HPETLVKVKDAEDQLGARVG Y 026-046 1 3 10 
SFRPEE 059-064 0 0 30 
VLLCGAVLSRVDA 074-086 0.05 1 32 
SRVDAGQEQLGRRIHYSQNDL 082-102 10 8 2 
SDNTANLLLTTI  130-142 0 0 0 
ANLLLTTI TTIGGPKEL 135-148 0 0 18 
DRWEPEL 161-167 0 0 33 
LRKLLTGELLTLASRQQLIDWE 188-210 12 10 2 
ATTLRKLLTG 185-194 0 10 10 
RKLLTGEL 191-198 5 5 33 
RKLLTGELL 191-199 5 5 33 
IDWMEA DKVAGPLLRSALPAGW 208-229 2 7 7 
DKVAGPLL 214-221 2 8 20 
GWFIADKSGAGERGSRGIIA 
ALGPDGKPSRIVV 
228-260 6 12 12 
FIADKSGAGERGSRGIIAALG 230-248 0 0 7 
IAEIGAS 275-281 0 0 0 
IGASL 280-284 0 0 33 
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Table 6.3:  All observed peptides with HDX levels, pre-mixing and two time-points post-
mixing with clavulanate. 
 
Sequence position Free enzyme 
128 ms 
(% labeled) 
Acyl-enzyme 
128 ms 
(% labeled) 
Acyl-enzyme 
10.0 s 
(% labeled) 
HPETL 026-030 10 10 30 
HPETLVKVKDAEDQLGARVG Y 026-046 1 3 22 
SFRPEE 059-064 0 0 0 
VLLCGAVLSRVDA 074-086 0.05 0 0 
SRVDAGQEQLGRRIHYSQNDL 082-102 10 2 2 
SDNTANLLLTTI  130-142 0 0 0 
ANLLLTTI TTIGGPKEL 135-148 0 0 0 
DRWEPEL 161-167 0 0 33 
LRKLLTGELLTLASRQQLIDWE 188-210 12 12 12 
ATTLRKLLTG 185-194 0 0 23 
RKLLTGEL 191-198 5 5 10 
RKLLTGELL 191-199 5 5 10 
IDWMEA DKVAGPLLRSALPAGW 208-229 2 7 7 
DKVAGPLL 214-221 2 8 20 
GWFIADKSGAGERGSRGIIA 
ALGPDGKPSRIVV 
228-260 6 12 12 
FIADKSGAGERGSRGIIAALG 230-248 0 0 0 
IAEIGAS 275-281 0 0 0 
IGASL 280-284 0 0 0 
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Figure 6.2. A comparison observed changes in dynamics associated with acylation caused by 
ampicillin, cephalexin and clavulanate on peptide DRWEPEL. (a) The peptide (161-167) is 
mapped on the 1FQG crystal structure of TEM-1. (b) HDX profile of the peptide.  
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82-102         SRVDAGQEQLSGRRIHYSQNDL 
 
 
 
 
 
 
 
 
Figure 6.3. A comparison observed changes in dynamics associated with acylation caused by 
ampicillin, cephalexin and clavulanate on peptide SRVDAGQEQLSGRRIHYSQNDL. (a) The 
peptide (82-102) is mapped on the 1FQG crystal structure of TEM-1. (b) HDX profile of the 
peptide.  
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Figure 6.4. A comparison observed changes in dynamics associated with acylation caused by 
ampicillin, cephalexin and clavulanate on peptide SDNTAANLLLTTI. (a) The peptide (105-
107) is mapped on the 1FQG crystal structure of TEM-1. (b) HDX profile of the peptide.  
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Figure 6.5. A comparison observed changes in dynamics associated with acylation caused by 
ampicillin, cephalexin and clavulanate on peptide FIADKSGAGERGSRGIIAA. (a) The peptide 
(205-223) is mapped on the 1FQG crystal structure of TEM-1. (b) HDX profile of the peptide.  
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This observation emphasizes the role of Glu166 in hydrolysis mechanism that does not 
occur in case of TEM-1/clavulanate system. However, the lower D-uptake by TEM-1/ampicillin 
system might be related to the acylation process. Ampicillin is a very good substrate of TEM-1 
that is readily hydrolyzed with an exceptionally high turnover rate [28]. Therefore, most 
probably this loop undergoes extremely rapid fluctuations during the hydrolysis process which is 
not measureable under our experimental conditions and the observed D- uptake is therefore an 
average of those impulsive motions. Another interesting phenomenon was observed by the 
peptide that is neighboring the active site Ser70.  In case of inhibitor, ‘tightening‘ of the region is 
observed which is suggestive of locking the active site while the enzyme generally ‘loosen up’ to 
hydrolyze substrates. Therefore, the observed HDX profile can be linked to the catalytically 
active sites (Figure 6.6). In NMR based studies, Trp229 residue has been identified as an 
important modulator of allosteric communication between active site and the allosteric site. 
Interestingly, the peptide  containing Trp229 residue shows exactly same dynamic profile in all 
three systems which also supports that this helix undergoes the same dynamics to serve the same 
purpose in all three cases [29]. 
 Remarkably, peptides that exhibit exclusively rapid changes display dramatic correlation 
with the naturally occurring mutation sites. The TEM-1 variants reported to the date exhibit 
either point or multiple mutations at the residues 39, 69, 104, 164,166, 205, 237, 238, 239, 240, 
244, 265 and 276 [10, 11, 17, 23, 25, 30]. Our observation suggests that all the residues are 
contained by the peptides that undergo dramatic structural change upon binding and/ or allosteric 
transition in all three systems that we have employed (Figure 6.2, 6.3, 6.4). In general, TEM-1 
conserves specific dynamic regions that demonstrate either positive or negative conformational 
response towards antibiotics.  
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Figure 6.6. Changes in TEM-1 conformational dynamics upon acylation as indicated by changes 
in deuterium uptake. (a,c,e) Immediately upon acylation. (b,d,f) Over time after acylation. Red 
indicates an increase in deuterium uptake, blue indicates a decrease and green indicates no 
change. In (a,c,e), grey regions indicate regions where no peptides were detected. In (b,d,f) all 
regions that do not exhibit a slow change in deuterium uptake are grey.  
AMPICILLIN: immediate binding  
CEPHALEXIN: immediate binding  
CLAVULANALANATE: immediate binding  
AMPICILLIN: allostery  
CEPHALEXIN: allostery 
CLAVULANALANATE: allostery  
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Additionally, these regions are either important for catalytic activity or transmission of 
allosteric information [20]. This striking correlation demonstrates the potential of microfluidics 
enabled HDX-TRESI-MS as a powerful technique to probe the possible site of functionally 
relevant mutations. Conventionally, mutation sites are prepared via PCR based site-directed 
mutagenesis experimental technique or predicted by molecular simulations which are labor 
intense and time consuming procedures [13, 31]. As our experimental approach is extremely 
straightforward and simple it can be adopted as an alternative method for the prediction of 
mutation sites via the detection of allostery.  
 
6.4 CONCLUSIONS 
We have successfully demonstrated the utility of pulse labeling microchip as a suitable 
approach for comparative study of allosteric effects on enzymes upon substrate/inhibitor binding.  
This is a versatile technique that can be generally applicable to any enzyme / ligand system (in 
principle) that involves structural perturbation as a consequence of binding. In contrast to 
complicated and exhaustive experimental methods that are generally employed to study dynamic 
response of enzymes towards ligands, the current experimental approach is extremely 
straightforward but provides enormous amount of information. We were able to identify the 
dynamic regions of TEM-1 beta-lactamase that are directly involved in acylation or in close 
proximity of active site. The result reveals that the regions that undergo time dependent and/or 
abrupt structural change after binding are specifically crucial for catalytic efficiency. 
Interestingly the peptides that experiences extreme changes, contains residues where most of the 
point mutations evolved naturally. To our best knowledge this is the first experimental approach 
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that can indirectly provide information about mutational ‘hot spots’ sites that must otherwise be 
obtained via complicated mutagenesis studies.  This strong correlation demonstrates the potential 
of this device in rapidly predicting possible sites of mutation and can be adopted as a powerful 
novel approach.  
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CHAPTER 7 
 
SUMMARY AND FUTURE DIRECTION 
 
This thesis introduces a simple, cost effective and highly reproducible microfluidic 
device fabrication protocol which enables integration of multiple functionalities on a common 
platform to develop custom polymeric microfluidic devices.  These devices are directly 
interfaced with mass spectrometry as an alternative electrospray ionization source to conduct site 
specific mass spectrometric analysis on protein samples. This thesis also describes the 
application of these microfluidic devices in studying proteins dynamics and/or kinetics of weakly 
structured proteins and/or intrinsically disordered proteins that are unattainable by other 
conventional biophysical techniques.  
Chapter 2 introduces a quick, economical, straightforward and highly reproducible 
fabrication protocol that is suitable for rapid prototyping.  Using this new technique, a 
microfluidic module was developed that supports millisecond time scale rapid mixing followed 
by mass spectrometric analysis. The device performance was verified by an acid induced 
unfolding of cytochrome c. An analytical frame work for analyzing the resultant data was also 
introduced. This microfluidic device enables us to identify a previously unreported native-like 
intermediate in the acid induced unfolding of cytochrome c.  
In Chapter 3, we successfully introduce a novel multistep microfluidic reactor that 
incorporates entire MS based HDX work flow on a single platform enabling direct 
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measurements of rapid fluctuations in proteins on millisecond time-scale on a single online 
experiment.  The microfluidic framework provides rapid mixing and continuous labeling on 
millisecond timescale followed by rapid quenching of labeling reaction for proteolytic 
degradation which was then directly introduced to Mass spectrometer. The device performance 
was tested by acquiring a single time point (100 ms) measurement of native state ubiquitin.  
HDX profile of ubiquitin was achieved through extensive data analysis which enables structural 
analysis of native state ubiquitin and clearly demonstrates the potential application of this 
integrated device. 
This unique device is also applied to achieve a detailed time course HDX profile of 
native state cytochrome c (80ms to 10s) at physiological pH 7.6 which enables us to distinguish 
the dynamic behaviour of different loops at ms time scale. The observed dynamics suggests a 
reasonable agreement between the reported X-ray structure and the solution conformation under 
our experimental condition. Only the „heme‟ bound loop showed significant deviation suggesting 
that this approach can clearly demonstrate and distinguish loop dynamics. Our observations 
correlate well with studies conducted in other orthogonal manner (HDX NMR) but appear to be 
much easier to conduct which shows the potential of this device to be adopted as an alternative 
methodology for studying protein conformations.  
This integrated continuous labeling device is also applied to established the dynamics of 
DAHP synthase in absence of its substrate and compared to its available substrate bound crystal 
structure (1KFL) through acquiring HDX profile of free DAHP synthase (40 ms to 10 sec).  Our 
data suggests that the free and the substrate bound forms have structural similarities only at the 
tetramer interface but significantly differ near the active site of the enzyme which suggests that 
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the unbound enzyme undergoes „molten-globule-like‟ conformational dynamics. Differences in 
the dynamics are concentrated to a region surrounding the active site which is largely helical in 
the substrate-bound species. But this region shows loop-like dynamics in the unbound protein 
which develops into partial structures upon substrate binding.  
Chapter 4 is a continuation work of Chapter 3 where conformational changes in DAHP 
synthase upon ligand (substrate and different inhibitors) binding are probed via continuous 
labeling HDX experiments. Extensive data analysis helps us to characterize substantial 
differences in dynamics near the active sites of the enzymes among the apo and different holo 
enzymes. This work can be further extended by investigating global HDX of tetramer with 
response to all of these small molecules (substrates/ inhibitor) followed by a rapid degradation 
into individual monomers prior to ionization. This proposed experiment can provide us 
information about the asymmetric binding of the subunits and eventually will be beneficial in 
finding the differential dynamic behaviour of the individual monomers. 
Chapter 5 introduces a pulse labeling microfluidic device that is complementary to the 
device described in Chapter 3. This integrated microfluidic reactor enables direct measurement 
of structural changes and dynamics in TEM1 β-lactamase protein due to allosteric inhibition. The 
observed results show some fascinating correlations with mutagenesis studies that  demonstrates 
the power of microfluidics enabled sub-second HDX pulse labeling as a tool for studying 
allostery.  
The utility of this microchip is further extended in Chapter 6 where it is applied for 
comparative study of allosteric effects on TEM-1 upon binding to its inhibitor, good and poor 
substrates.  The result indicates that the regions that exhibit time dependent dynamic behaviour 
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after binding are the regions where most of the mutations occur naturally. This intriguing 
correlation demonstrates the potential of this device in predicting possible sites of functionally 
relevant mutation and can be adopted as a novel approach in measuring allosteric interaction to 
predict possible sites of mutation.  
In recent years, MS based HDX technique has significantly contributed in characterizing 
biopharmaceuticals. HDX-MS provides detailed information of inherent specificity of small drug 
targets with large protein molecules [1]. The approach of this dissertation work is not limited to 
only studying protein conformations but can also be stretched to active surface guided drug 
designing by measuring effect of protein- drug binding. Inherent specificity of a possible drug 
candidate and their alternative modes of action can be determined effectively using our 
microfluidic reactor facilitating Epitope mapping. Epitope mapping on microfluidic platform is 
an innovative approach and therefore we have applied for an intellectual property (patent) to 
Innovation York titled „Time-resolved Hydrogen Deuterium Exchange With Spatial Resolution 
for Epitope Mapping‟ which is currently under review process at MaRS innovation Centre, ON.   
Our microfluidic TR-ESI reactor is advantageous compare to all other contemporary MS 
and NMR based analytical techniques that utilizes HDX. In conventional experimental 
approaches, LC separation is an essential step which is not required in our experimental set up 
reducing the experimental period significantly. Using microfluidic platform, a complete data 
acquisition period for acquiring 10 HDX time points is less than 2 hours for one protein sample. 
This is advantageous in epitope mapping as many antigen and/or antigen-monoclonal antibody 
complex have short life span and requires quick data acquisition. NMR and MS based 
conventional HDX techniques are compared with microfluidic TR-ESI reactor in Table 7.1. 
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Table 7.1. Comparison of microfluidic TR-ESI rector with contemporary analytical techniques 
using HDX in protein conformational studies 
 
 
Microfluidic 
TRESI HDX-MS 
Conventional 
HDX-MS 
Conventional 
HDX-NMR 
Sample quality Moderately pure Moderately pure Pure 
Solvent 
compatibility 
LC-MS friendly 
buffer or solvent 
and non-reacting 
with PMMA 
Any LC-MS 
friendly buffer or 
solvent 
Deuterated NMR 
solvent where the 
peptides are 
soluble 
Total data 
acquisition period 
per time point 
8 s 30 min to 1 hr 30 min to 1 hr 
Data acquisition 
period per scan 
Milliseconds Milliseconds Few seconds 
HDX labeling time 40 ms to 24 hrs 1 hr to 24 hr 1hr to 24 hr 
LC separation Not required  15 min to 8 hr  15 min to 8 hr 
Online/offline 
measurement 
Online Online Offline 
Temperature 
controller 
Not required Required Required 
Data Interpretation Manual Software assisted Manual 
 
Due to the novelty and simplicity of our approach, many MS-based industries have 
shown interest in our microfluidic enabled ESI source. Currently we are in a process of 
collaboration with industries for commercialization of our enzymatic micro-reactor which will 
also integrate our approach with currently available data analysis software.  Proper software 
assisted data interpretation can reduce the data analysis time significantly which is the only 
downside of TRESI compared to currently available commercial techniques. Commercialization 
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of this micro-reactor will significantly increase the scope of HDX-MS and hopefully the HDX 
community will embrace this technique to explore many innovative applications including 
routine investigation of drug targets. 
The scope of this dissertation work can be further extended through integrating more 
functional modules and also by improving the existing fabrication technique. Furthermore, these 
integrated devices can be interfaced with a high resolution MS which is capable of performing 
ion mobility on the resulting peptides to demonstrate further conformational information. Since 
ECD or ETD techniques are not amenable to large proteins, it is not possible to obtain single 
spatial resolution on huge protein or protein-complex samples.  In those cases, these devices can 
be applied as a “middle-down” approach to generate relatively smaller peptides than intact 
protein which are easily subjected to ECD or ETD fragmentation.   
With the advents in MS instrumentation, software and methodologies, HDX is becoming 
more dominating technique in studying protein conformations, epitope mapping, comparability 
study and higher order protein structure determination [2]. Our device is a promising addition 
which allows incorporation of many new functionality such as desalting module and/or 
separation module if required for such studies.  These micro reactors are powerful tools that 
might have many other fascinating applications which need to be explored in future.  
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